10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2020

or

◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to            

Commission File Number 001-33387

GSI Technology, Inc.

(Exact name of registrant as specified in its charter)

Delaware	77-0398779
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

1213 Elko Drive

Sunnyvale, California 94089

(Address of principal executive offices, zip code)

(408) 331-8800

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class	Trading Symbol(s)	Name of Each Exchange on which Registered
Common Stock, $0.001 par value	GSIT	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ⌧  No  ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ⌧  No  ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ◻	Accelerated filer  ◻
Non-accelerated filer  ⌧	Smaller reporting company  ⌧
	Emerging growth company  ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ◻  No  ⌧

The number of shares of the registrant’s common stock outstanding as of January 31, 2021: 23,797,963.

GSI TECHNOLOGY, INC.

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2020

		Page
PART I — FINANCIAL INFORMATION
Item 1.	Financial Statements	2
	Condensed Consolidated Balance Sheets	2
	Condensed Consolidated Statements of Operations	3
	Condensed Consolidated Statements of Comprehensive Loss	4
	Condensed Consolidated Statements of Stockholders’ Equity	5
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28
Item 4.	Controls and Procedures	28
	PART II — OTHER INFORMATION
Item 1A.	Risk Factors	28
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	44
Item 6.	Exhibits	45
Signatures		46

1

PART I — FINANCIAL INFORMATION

Item 1.Financial Statements

GSI TECHNOLOGY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

	December 31,		March 31,
	2020		2020
	(In thousands, except share and per share amounts)
ASSETS
Cash and cash equivalents	$	43,064	$	51,506
Short-term investments		9,196		15,061
Accounts receivable, net		4,012		6,330
Inventories		4,523		4,282
Prepaid expenses and other current assets		1,979		1,934
Total current assets		62,774		79,113
Property and equipment, net		7,444		8,119
Operating lease right-of-use assets		817		617
Long-term investments		10,126		4,117
Goodwill		7,978		7,978
Intangible assets, net		2,314		2,489
Other assets		139		128
Total assets	$	91,592	$	102,561
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable	$	2,422	$	1,184
Lease liabilities, current		457		498
Accrued expenses and other liabilities		5,525		6,578
Total current liabilities		8,404		8,260
Income taxes payable		334		620
Lease liabilities, non-current		403		142
Contingent consideration, non-current		3,972		3,898
Total liabilities		13,113		12,920
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock: $0.001 par value authorized: 5,000,000 shares; issued and outstanding: none		—		—
Common Stock: $0.001 par value authorized: 150,000,000 shares; issued and outstanding: 23,795,963 and 23,229,286 shares, respectively		24		23
Additional paid-in capital		45,602		40,176
Accumulated other comprehensive income		5		71
Retained earnings		32,848		49,371
Total stockholders’ equity		78,479		89,641
Total liabilities and stockholders’ equity	$	91,592	$	102,561

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

GSI TECHNOLOGY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands, except per share amounts)
Net revenues	$	6,763	$	10,049	$	20,043	$	34,808
Cost of revenues		3,566		4,000		10,684		13,948
Gross profit		3,197		6,049		9,359		20,860
Operating expenses:
Research and development		5,736		8,208		17,220		19,636
Selling, general and administrative		2,612		2,584		8,138		8,119
Total operating expenses		8,348		10,792		25,358		27,755
Loss from operations		(5,151)		(4,743)		(15,999)		(6,895)
Interest income, net		50		190		244		610
Other income (expense), net		(25)		17		(129)		(46)
Loss before income taxes		(5,126)		(4,536)		(15,884)		(6,331)
Provision for income taxes		90		84		639		182
Net loss	$	(5,216)	$	(4,620)	$	(16,523)	$	(6,513)
Net loss per share:
Basic	$	(0.22)	$	(0.20)	$	(0.70)	$	(0.28)
Diluted	$	(0.22)	$	(0.20)	$	(0.70)	$	(0.28)
Weighted average shares used in per share calculations:
Basic		23,716		23,096		23,592		22,894
Diluted		23,716		23,096		23,592		22,894

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

GSI TECHNOLOGY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands)
Net loss	$	(5,216)	$	(4,620)	$	(16,523)	$	(6,513)
Net unrealized gain (loss) on available-for-sale investments		(38)		(11)		(66)		54
Total comprehensive loss	$	(5,254)	$	(4,631)	$	(16,589)	$	(6,459)

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

GSI TECHNOLOGY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Unaudited)

						Accumulated
				Additional		Other				Total
	Common Stock			Paid-in		Comprehensive		Retained		Stockholders'
	Shares	Amount		Capital		Income (Loss)		Earnings		Equity
Three months ended December 31, 2020	(In thousands, except share amounts)
Balance, September 30, 2020	23,641,426	$	24	$	44,092	$	43	$	38,064	$	82,223
Issuance of common stock under employee stock option plans	154,537		—		817		—		—		817
Stock-based compensation expense	—		—		693		—		—		693
Net loss	—		—		—		—		(5,216)		(5,216)
Net unrealized loss on available-for-sale investments	—		—		—		(38)		—		(38)
Balance, December 31, 2020	23,795,963	$	24	$	45,602	$	5	$	32,848	$	78,479
Three months ended December 31, 2019
Balance, September 30, 2019	23,052,473	$	23	$	37,903	$	28	$	57,815	$	95,769
Issuance of common stock under employee stock option plans	80,525		—		480		—		—		480
Stock-based compensation expense	—		—		629		—		—		629
Net loss	—		—		—		—		(4,620)		(4,620)
Net unrealized loss on available-for-sale investments	—		—		—		(11)		—		(11)
Balance, December 31, 2019	23,132,998	$	23	$	39,012	$	17	$	53,195	$	92,247

						Accumulated
				Additional		Other				Total
	Common Stock			Paid-in		Comprehensive		Retained		Stockholders'
	Shares	Amount		Capital		Income (Loss)		Earnings		Equity
Nine months ended December 31, 2020	(In thousands, except share amounts)
Balance, March 31, 2020	23,229,286	$	23	$	40,176	$	71	$	49,371	$	89,641
Issuance of common stock under employee stock option plans	566,677		1		3,325		—		—		3,326
Stock-based compensation expense	—		—		2,101		—		—		2,101
Net loss	—		—		—		—		(16,523)		(16,523)
Net unrealized loss on available-for-sale investments	—		—		—		(66)		—		(66)
Balance, December 31, 2020	23,795,963	$	24	$	45,602	$	5	$	32,848	$	78,479
Nine months ended December 31, 2019
Balance, March 31, 2019	22,320,156	$	22	$	33,462	$	(37)	$	59,708	$	93,155
Issuance of common stock under employee stock option plans	812,842		1		3,628		—		—		3,629
Stock-based compensation expense	—		—		1,922		—		—		1,922
Net loss	—		—		—		—		(6,513)		(6,513)
Net unrealized gain on available-for-sale investments	—		—		—		54		—		54
Balance, December 31, 2019	23,132,998	$	23	$	39,012	$	17	$	53,195	$	92,247

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

GSI TECHNOLOGY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended December 31,
	2020		2019
	(In thousands)
Cash flows from operating activities:
Net loss	$	(16,523)	$	(6,513)
Adjustments to reconcile net loss to net cash used in operating activities:
Allowance for doubtful accounts and other		(25)		(32)
Provision for excess and obsolete inventories		327		260
Non-cash lease expense		458		462
Depreciation and amortization		962		1,079
Stock-based compensation		2,101		1,922
Amortization of premium (discount) on investments		49		(14)
Changes in assets and liabilities:
Accounts receivable		2,343		1,973
Inventory		(568)		904
Prepaid expenses and other assets		(56)		(1,064)
Accounts payable		1,238		(728)
Accrued expenses and other liabilities		(1,693)		531
Net cash used in operating activities		(11,387)		(1,220)
Cash flows from investing activities:
Purchase of investments		(17,509)		(15,866)
Maturities of short-term investments		17,250		18,626
Decrease in MikaMonu escrow deposit		—		1,000
Purchases of property and equipment		(122)		(265)
Net cash provided by (used in) investing activities		(381)		3,495
Cash flows from financing activities:
Payment of MikaMonu escrow deposit		—		(428)
Proceeds from issuance of common stock under employee stock plans		3,326		3,629
Net cash provided by financing activities		3,326		3,201
Net increase (decrease) in cash and cash equivalents		(8,442)		5,476
Cash and cash equivalents at beginning of the period		51,506		42,495
Cash and cash equivalents at end of the period	$	43,064	$	47,971
Non-cash investing and financing activities:
Purchases of property and equipment through accounts payable and accruals	$	9	$	24
Operating lease right-of-use assets exchanged for lease obligations	$	658	$	1,228
Supplemental cash flow information:
Net cash paid for income taxes	$	857	$	310

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

GSI TECHNOLOGY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1—THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The accompanying unaudited condensed consolidated financial statements of GSI Technology, Inc. and its subsidiaries (“GSI” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission.  Accordingly, the interim financial statements do not include all of the information and footnotes required by GAAP for annual financial statements.  These interim financial statements contain all adjustments (which consist of only normal, recurring adjustments) that are, in the opinion of management, necessary to state fairly the interim financial information included therein.  The Company believes that the disclosures are adequate to make the information not misleading.  However, these financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

The consolidated results of operations for the nine months ended December 31, 2020 are not necessarily indicative of the results to be expected for the entire fiscal year.

Significant accounting policies

Except for the changes in disclosure requirements for recurring and nonrecurring fair value measurements and changes in goodwill impairment testing, which were updated as a result of adopting new accounting standards, there have been no material changes to our significant accounting policies that were disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

Risk and uncertainties

On March 11, 2020, the World Health Organization announced that COVID-19, a respiratory illness caused by a novel coronavirus, is a pandemic. COVID-19 has spread to many of the countries in which the Company, its customers, suppliers and other business partners conduct business. Governments in affected regions have implemented, and may continue to implement, safety precautions which include quarantines, travel restrictions, business closures, cancellations of public gatherings and other measures as they deem necessary. Many organizations and individuals, including the Company and its employees, are taking additional steps to avoid or reduce infection, including limiting travel and working from home. These measures are disrupting normal business operations both in and outside of affected areas and have had significant negative impacts on businesses and financial markets worldwide.

The Company continues to monitor its operations and government recommendations and has made modifications to its normal operations because of the COVID-19 global pandemic. The Company has instituted many preventative measures and is regularly evaluating those measures and others as it continues to better understand its current and future operating environment. Except for the Company’s employees located in Taiwan, the majority of its employees are working from home around the world. The Company has maintained a substantial portion of its manufacturing operational capacity at its primary manufacturing support facility located in Hsin Chu, Taiwan where the Company’s suppliers are located and where all of the Company’s products are manufactured. Since the outbreak of COVID-19, aside from the lengthening of lead times for wafers and assembly services, the Company has experienced minimal impact on its manufacturing operations in Taiwan. Final testing of the Company’s products is conducted in house. Shipping and receiving operations are being maintained by a skeleton crew with minimal impact. The Company’s revenues have been and are expected to continue to be impacted by changes in customer buying patterns and communication limitations related to shelter in place restrictions that

7

require a significant number of its customer contacts to work from home. The Company’s results for the three month and nine month periods ended December 31, 2020 demonstrate the challenges that the Company is facing during the COVID-19 global pandemic, which has restricted the activities of the Company’s sales force and distributors, reduced customer demand and caused the postponement of investment in certain customer sectors. These challenges are also impacting the Company as it enters new markets and engages with target customers. Industry conferences and on-site training workshops, which are typically used for building a sales pipeline, are unavailable due to COVID-19 related restrictions. The Company has adapted its sales strategies for the COVID-19 environment, where it cannot do face-to-face meetings and conduct secure meetings with government and defense customers, but the Company is still not operating at an optimal level.

The disruption to the marketplace resulting from the COVID-19 global pandemic that the Company continues to experience is unlike anything the Company has ever had to deal with. While the Company continues to monitor the business metrics that it has historically used to predict its financial performance, the Company is uncertain as to whether these metrics will operate consistently with its historical experience.

The Company believes that during the next 12 months the COVID-19 pandemic could impact general economic activity and demand in its end markets. Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it is expected to have an adverse effect on the Company’s results of operations, financial position, and liquidity during fiscal year 2021 and into fiscal year 2022. This includes results from new information that may emerge concerning COVID-19 and any actions taken to contain or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. The Company has made estimates of the impact of COVID-19 within its financial statements and there may be changes to those estimates in future periods.

Accounting pronouncements recently adopted

In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement.” The standard amends the disclosure requirements for recurring and nonrecurring fair value measurements by removing, modifying, and adding certain disclosures. The Company adopted ASU No. 2018-13 in the quarter ended June 30, 2020.Implementation of this guidance did not have a material impact on the Company’s consolidated financial statements and related disclosures.

In January 2017, the FASB issued ASU No. 2017-04, "Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The standard eliminates the second step in the goodwill impairment test which requires an entity to determine the implied fair value of the reporting unit’s goodwill.  Instead, an entity should recognize an impairment loss if the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, with the impairment loss not to exceed the amount of goodwill allocated to the reporting unit. The Company adopted ASU No. 2017-04 in the quarter ended June 30, 2020.Implementation of this guidance did not have a material impact on the Company’s consolidated financial statements and related disclosures.

Accounting pronouncements not yet effective for fiscal 2021

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” as part of its initiative to reduce complexity in the accounting standards. The standard eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact that this guidance will have upon its financial position and results of operations, if any.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other

8

receivables, loans, and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted beginning April 1, 2019. Application of the amendments is through a cumulative-effect adjustment to retained earnings as of the effective date. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

NOTE 2—REVENUE RECOGNITION

The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, we satisfy a performance obligation.

The majority of the Company’s customer contracts, which may be in the form of purchase orders, contracts or purchase agreements, contain performance obligations for delivery of agreed upon products. Delivery of all performance obligations contained within a contract with a customer typically occurs at the same time (or within the same accounting period). Transfer of control typically occurs at the time of shipment or at the time the product is pulled from consignment as that is the point at which delivery has occurred, title and the risks and rewards of ownership have passed to the customer, and the Company has a right to payment. Thus, the Company will generally recognize revenue upon shipment of the product.

Because all of the Company’s performance obligations relate to contracts with a duration of less than one year, the Company has elected to apply the optional exemption practical expedient provided in ASC 606 and, therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

The Company adjusts the transaction price for variable consideration. Variable consideration is not typically significant and primarily results from stock rotation rights and quick pay discounts provided to certain distributors. As a practical expedient, the Company is recognizing the incremental costs of obtaining a contract, specifically commission expenses that have a period of benefit of less than twelve months, as an expense when incurred. Additionally, the Company has adopted an accounting policy to recognize shipping costs that occur after control transfers to the customer as a fulfillment activity.

The Company’s contracts with customers do not typically include extended payment terms. Payment terms vary by contract type and type of customer and generally range from 30 to 60 days from shipment. Additionally, the Company has right to payment upon shipment.

The Company records revenue net of sales tax, value added tax, excise tax and other taxes collected concurrent with product sales. The impact of such taxes on products sales is immaterial. The Company has also elected to recognize the cost for freight and shipping when control over the products sold passes to customers and revenue is recognized.

The Company warrants its products to be free of defects generally for a period of three years. The Company estimates its warranty costs based on historical warranty claim experience and includes such costs in cost of revenues. Warranty costs and the accrued warranty liability were not material as of December 31, 2020.

The majority of the Company’s revenue is derived from sales of SRAM products which represent approximately 98% of total revenues in the nine months ended December 31, 2020.

Nokia, the Company’s largest customer, purchases products directly from the Company and through contract manufacturers and distributors. Based on information provided to the Company by its contract manufacturers and

9

distributors, purchases by Nokia represented approximately 40% of the Company’s net revenues in the nine months ended December 31, 2020 and 2019.

See “Note 12 — Segment and Geographic Information” for revenue by shipment destination.

The following table presents the Company’s revenue disaggregated by customer type.

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands)
Contract manufacturers	$	3,154	$	3,022	$	9,007	$	11,745
Distribution		3,586		6,603		10,692		21,346
OEMs		23		424		344		1,717
	$	6,763	$	10,049	$	20,043	$	34,808

NOTE 3—NET LOSS PER COMMON SHARE

The Company uses the treasury stock method to calculate the weighted average shares used in computing diluted net loss per share. The following table sets forth the computation of basic and diluted net loss per share:

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands, except per share amounts)
Net loss	$	(5,216)	$	(4,620)	$	(16,523)	$	(6,513)
Denominators:
Weighted average shares—Basic		23,716		23,096		23,592		22,894
Dilutive effect of employee stock options		—		—		—		—
Dilutive effect of employee stock purchase plan options		—		—		—		—
Weighted average shares—Dilutive		23,716		23,096		23,592		22,894
Net loss per common share—Basic	$	(0.22)	$	(0.20)	$	(0.70)	$	(0.28)
Net loss per common share—Diluted	$	(0.22)	$	(0.20)	$	(0.70)	$	(0.28)

The following shares of common stock underlying outstanding stock options, determined on a weighted average basis, were excluded from the computation of diluted net loss per share as they had an anti-dilutive effect:

	Three Months Ended December 31,		Nine Months Ended December 31,
	2020	2019	2020	2019
	(In thousands)
Shares underlying options and ESPP shares	5,181	4,048	4,856	3,762

10

NOTE 4—BALANCE SHEET DETAIL

	December 31, 2020		March 31, 2020
	(In thousands)
Inventories:
Work-in-progress	$	1,924	$	1,650
Finished goods		2,572		2,612
Inventory at distributors		27		20
	$	4,523	$	4,282

	December 31, 2020		March 31, 2020
	(In thousands)
Accounts receivable, net:
Accounts receivable	$	4,072	$	6,415
Less: Allowances for doubtful accounts and other		(60)		(85)
	$	4,012	$	6,330

	December 31, 2020		March 31, 2020
	(In thousands)
Prepaid expenses and other current assets:
Prepaid tooling and masks	$	783	$	707
Prepaid income taxes		45		79
Other receivables		234		211
Other prepaid expenses and other current assets		917		937
	$	1,979	$	1,934

	December 31, 2020		March 31, 2020
	(In thousands)
Property and equipment, net:
Computer and other equipment	$	18,289	$	18,191
Software		4,097		4,086
Land		3,900		3,900
Building and building improvements		3,735		3,735
Furniture and fixtures		102		102
Leasehold improvements		877		874
		31,000		30,888
Less: Accumulated depreciation		(23,556)		(22,769)
	$	7,444	$	8,119

Depreciation expense was $197,000 and $293,000 for the three months ended December 31, 2020 and 2019, respectively, and $787,000 and $904,000 for the nine months ended December 31, 2020 and 2019, respectively.

11

	December 31, 2020		March 31, 2020
	(In thousands)
Other assets:
Deposits	$	139	$	128
	$	139	$	128

The following tables summarize the components of intangible assets and related accumulated amortization balances at December 31, 2020 and March 31, 2020 (in thousands):

	As of December 31, 2020
	Gross Carrying Amount		Accumulated amortization		Net Carrying Amount
Intangible assets:
Product designs	$	590	$	(590)	$	—
Patents		4,220		(1,906)		2,314
Software		80		(80)		—
Total	$	4,890	$	(2,576)	$	2,314

	As of March 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Intangible assets:
Product designs	$	590	$	(590)	$	—
Patents		4,220		(1,731)		2,489
Software		80		(80)		—
Total	$	4,890	$	(2,401)	$	2,489

Amortization of intangible assets included in cost of revenues was $58,000 and $58,000 for the three months ended December 31, 2020 and 2019, respectively, and $175,000 and $175,000 for the nine months ended December 31, 2020 and 2019, respectively.

As of December 31, 2020, the estimated future amortization expense of intangible assets in the table above is as follows (in thousands):

Fiscal year ending March 31,
2021 (Remaining three months)	$	58
2022		233
2023		233
2024		233
2025		233
Thereafter		1,324
Total	$	2,314

12

	December 31, 2020		March 31, 2020
	(In thousands)
Accrued expenses and other liabilities:
Accrued compensation	$	3,959	$	3,673
Purchased intellectual property		—		1,621
Accrued commissions		223		270
Income taxes payable		211		143
Miscellaneous accrued expenses		1,132		871
	$	5,525	$	6,578

NOTE 5—GOODWILL

Goodwill represents the difference between the purchase price and the estimated fair value of the identifiable assets acquired and liabilities assumed in a business combination. The Company tests for goodwill impairment on an annual basis, or more frequently if events or changes in circumstances indicate that the asset is more likely than not impaired. The Company has one reporting unit. The Company assesses goodwill for impairment on an annual basis on the last day of February in the fourth quarter of its fiscal year.

The Company had a goodwill balance of $8.0 million as of both March 31, 2020 and December 31, 2020. The goodwill resulted from the acquisition of MikaMonu Group Ltd. in fiscal 2016.

The Company utilized a two-step quantitative analysis to complete its annual impairment test during the fourth quarter of fiscal 2020 and concluded that there was no impairment, as the fair value of its sole reporting unit exceeded its carrying value. The Company determined that the second step of the impairment test was not necessary. No triggering event took place subsequent to the fiscal 2020 annual assessment that necessitated a quantitative impairment analysis for the Company’s one reporting unit.

NOTE 6—INCOME TAXES

The current portion of the Company’s unrecognized tax benefits was $0 at both December 31, 2020 and March 31, 2020. The long-term portion at December 31, 2020 and March 31, 2020 was $326,000 and $613,000, respectively, of which the timing of the resolution is uncertain.  As of December 31, 2020, $3.0 million of unrecognized tax benefits had been recorded as a reduction to net deferred tax assets.  As of December 31, 2020, the Company’s net deferred tax assets of $12.4 million were subject to a valuation allowance of $12.4 million. As of March 31, 2020, the Company’s net deferred tax assets of $9.4 million were subject to a valuation allowance of $9.4 million.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted. The CARES Act is an approximate $2 trillion emergency economic stimulus package passed in response to the COVID-19 global pandemic. The CARES Act contains numerous income tax provisions including changes to the net operating loss rules that the Company believes will not have a significant impact.

Management believes that within the next twelve months the Company will not have a significant reduction in uncertain tax benefits, including interest and penalties, related to positions taken with respect to credits and loss carryforwards on previously filed tax returns.

The Company’s policy is to include interest and penalties related to unrecognized tax benefits within the provision for income taxes in the Condensed Consolidated Statements of Operations.

The Company is subject to taxation in the United States and various state and foreign jurisdictions.  Fiscal years 2013 through 2020 remain open to examination by federal tax authorities, and fiscal years 2012 through 2020 remain open to examination by California tax authorities. During the quarter ended June 30, 2020, the Company

13

settled an income tax audit in Israel for fiscal years 2016 through 2019 that resulted in a discrete tax provision of $479,000 and a tax liability of $713,000 as of June 30, 2020 that was paid in the quarter ended September 30, 2020.

The Company’s estimated annual effective income tax rate, including discrete items, was approximately (3.4%) and (2.2%) as of December 31, 2020 and 2019, respectively. The annual effective tax rates as of December 31, 2020 and 2019 vary from the United States statutory income tax rate primarily due to valuation allowances in the United States, whereby pre-tax losses do not result in the recognition of corresponding income tax benefits and expenses and the foreign tax differential.

NOTE 7—FINANCIAL INSTRUMENTS

Fair value measurements

Authoritative accounting guidance for fair value measurements provides a framework for measuring fair value and related disclosures. The guidance applies to all financial assets and financial liabilities that are measured on a recurring basis. The guidance requires fair value measurement to be classified and disclosed in one of the following three categories:

Level 1: Valuations based on quoted prices in active markets for identical assets and liabilities.  The fair value of available-for-sale securities included in the Level 1 category is based on quoted prices that are readily and regularly available in an active market.  As of December 31, 2020, the Level 1 category included money market funds of $23.2 million, which were included in cash and cash equivalents on the Condensed Consolidated Balance Sheets.

Level 2: Valuations based on observable inputs (other than Level 1 prices), such as quoted prices for similar assets at the measurement date; quoted prices in markets that are not active; or other inputs that are observable, either directly or indirectly. The fair value of available-for-sale securities included in the Level 2 category is based on the market values obtained from an independent pricing service that were evaluated using pricing models that vary by asset class and may incorporate available trade, bid and other market information and price quotes from well-established independent pricing vendors and broker-dealers. As of December 31, 2020, the Level 2 category included short-term investments of $9.2 million and long-term investments of $10.1 million, which were comprised of certificates of deposit, government and agency securities.

Level 3: Valuations based on inputs that are unobservable and involve management judgment and the reporting entity’s own assumptions about market participants and pricing.  As of December 31, 2020, the Company’s Level 3 financial instruments measured at fair value on the Condensed Consolidated Balance Sheets consisted of the contingent consideration liability related to the acquisition of MikaMonu. The fair value of the contingent consideration liability was initially determined as of the acquisition date using unobservable inputs. These inputs included the estimated amount and timing of future cash flows, the probability of success (achievement of the various contingent events) and a risk-adjusted discount rate of approximately 14.8% used to adjust the probability-weighted cash flows to their present value. Significant increases (decreases) in any of those inputs in isolation would result in a significantly higher (lower) fair value measurement. Generally, changes used in the assumptions for future cash flows and probability of success would be accompanied by a directionally similar change in the fair value measurement and expense. Conversely, changes in the risk-adjusted discount rate would be accompanied by a directionally opposite change in the related fair value measurement and expense. Subsequent to the acquisition date, at each reporting period, the contingent consideration liability is re-measured to fair value with changes recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations. During the most recent re-measurement of the contingent consideration liability as of March 31, 2020, the Company used a risk-adjusted discount rate of approximately 14.5% to adjust the probability-weighted cash flows to their present value using probabilities ranging from 0% to 10% for the remaining contingent events. The contingent consideration liability is included in contingent consideration, non-current on the Consolidated Balance Sheet at December 31, 2020 and March 31, 2020 in the amount of $4.0 million and $3.9 million, respectively.

14

The fair value of financial assets measured on a recurring basis is as follows (in thousands):

			Fair Value Measurements at Reporting Date Using
			Quoted Prices
			in Active		Significant
			Markets for		Other		Significant
			Identical Assets		Observable		Unobservable
			and Liabilities		Inputs		Inputs
	December 31, 2020		(Level 1)		(Level 2)		(Level 3)
Assets:
Money market funds	$	23,160	$	23,160	$	—	$	—
Marketable securities		19,322		—		19,322		—
Total	$	42,482	$	23,160	$	19,322	$	—
Liabilities:
Contingent consideration	$	3,972	$	—	$	—	$	3,972

			Fair Value Measurements at Reporting Date Using
			Quoted Prices
			in Active		Significant
			Markets for		Other		Significant
			Identical Assets		Observable		Unobservable
			and Liabilities		Inputs		Inputs
	March 31, 2020		(Level 1)		(Level 2)		(Level 3)
Assets:
Money market funds	$	14,117	$	14,117	$	—	$	—
Marketable securities		19,178		—		19,178		—
Total	$	33,295	$	14,117	$	19,178	$	—
Liabilities:
Contingent consideration	$	3,898	$	—	$	—	$	3,898

The following table sets forth the changes in fair value of contingent consideration for the nine months ended December 31, 2020 and December 31, 2019:

	Nine Months Ended December 31,
	2020		2019
	(In thousands)
Contingent consideration, beginning of period	$	3,898	$	4,206
Change due to accretion		74		87
Payment of contingent consideration		—		(500)
Contingent consideration, end of period	$	3,972	$	3,793

Short-term and long-term investments

All of the Company’s short-term and long-term investments are classified as available-for-sale.  Available-for-sale debt securities with maturities greater than twelve months are classified as long-term investments when they are not intended for use in current operations.  Investments in available-for-sale securities are reported at fair value with unrecognized gains (losses), net of tax, as a component of accumulated other comprehensive loss in the Condensed Consolidated Balance Sheets.  The Company had money market funds of $23.2 million and $14.1 million at December 31, 2020 and March 31, 2020, respectively, included in cash and cash equivalents on the Condensed Consolidated Balance Sheets.  The Company monitors its investments for impairment periodically and records appropriate reductions in carrying values when declines are determined to be other-than-temporary.

15

The following table summarizes the Company’s available-for-sale investments:

	December 31, 2020
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
	(In thousands)
Short-term investments:
Certificates of deposit	$	2,495	$	14	$	—	$	2,509
Supranational obligations		2,765		5		—		2,770
Agency bonds		3,918		—		(1)		3,917
Total short-term investments	$	9,178	$	19	$	(1)	$	9,196
Long-term investments:
Certificates of deposit	$	4,000	$	31	$	—	$	4,031
Supranational obligations		2,047		—		(1)		2,046
Agency bonds		4,018		31		—		4,049
Total long-term investments	$	10,065	$	62	$	(1)	$	10,126

	March 31, 2020
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
	(In thousands)
Short-term investments:
Certificates of deposit	$	12,000	$	52	$	(1)	$	12,051
Agency bonds		2,989		21		—		3,010
Total short-term investments	$	14,989	$	73	$	(1)	$	15,061
Long-term investments:
Certificates of deposit	$	745	$	18	$	—	$	763
Agency bonds		2,029		42		—		2,071
Supranational obligations		1,270		13		—		1,283
Total long-term investments	$	4,044	$	73	$	—	$	4,117

The following table shows the gross unrealized losses and fair value of the Company’s investments with unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous loss position as of December 31, 2020 and March 31, 2020, respectively.

	December 31, 2020
	Less Than 12 Months				12 Months or Greater				Total
		Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
		Value		Loss		Value		Loss		Value		Loss
	(In thousands)
Agency bonds	$	4,918	$	(1)	$	—	$	—	$	4,918	$	(1)
Certificates of deposit		250		(1)		—		—		250		(1)
Supranational obligations		2,523		(1)		—		—		2,523		(1)
	$	7,691	$	(3)	$	—	$	—	$	7,691	$	(3)

	March 31, 2020
	Less Than 12 Months				12 Months or Greater				Total
		Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
		Value		Loss		Value		Loss		Value		Loss
	(In thousands)
Certificates of deposit	$	2,498	$	(2)	$	-	$	-	$	2,498	$	(2)
	$	2,498	$	(2)	$	-	$	-	$	2,498	$	(2)

16

The Company’s investment portfolio consists of both corporate and governmental securities that have a maximum maturity of three years. All unrealized gains and losses are due to changes in interest rates and bond yields. Subject to normal credit risks, the Company has the ability to realize the full value of all these investments upon maturity.

The deferred tax liability related to unrecognized gains and losses on short-term and long-term investments was $(22,000) and $(30,000) at December 31, 2020 and March 31, 2020, respectively.

As of December 31, 2020, contractual maturities of the Company’s available-for-sale investments were as follows:

			Fair
	Cost		Value
	(In thousands)
Maturing within one year	$	9,178	$	9,196
Maturing in one to three years		10,065		10,126
	$	19,243	$	19,322

The Company classifies its short-term investments as “available-for-sale” as they are intended to be available for use in current operations.

NOTE 8—LEASES

The Company has operating leases for corporate offices, research and development facilities, certain equipment and software. The Company’s leases have remaining lease terms of 2 months to 32 months, some of which include options to extend for up to 5 years.

Supplemental balance sheet information related to leases was as follows:

	As of		As of
	December 31, 2020		March 31, 2020
	(In thousands)
Operating Leases
Operating lease right-of-use assets	$	817	$	617
Lease liabilities-current	$	457	$	498
Lease liabilities-non-current		403		142
Total operating lease liabilities	$	860	$	640

The following table provides the details of lease costs:

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands)				(In thousands)
Operating lease cost	$	172	$	164	$	504	$	483
Short-term lease cost		8		7		23		21
	$	180	$	171	$	527	$	504

17

The following table provides other information related to leases:

	Nine Months Ended December 31,
	2020		2019
	(In thousands)
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	175	$	488
Right-of-use assets obtained in exchange for lease obligations
Operating leases	$	658	$	1,228
Weighted-average remaining lease term (years):
Operating leases		2.2		1.5
Weighted-average discount rate:
Operating leases		4.86%		6.46%

The following table provides the maturities of the Company’s operating lease liabilities as of December 31, 2020:

	Operating Lease
	Liabilities
Fiscal Year	(In thousands)
2021 (Remaining three months)	$	154
2022		395
2023		251
2024		102
Total undiscounted future cash flows		902
Less: Imputed interest		(42)
Present value of undiscounted future cash flows	$	860
Presentation on statement of financial position
Current	$	457
Non-current	$	403

NOTE 9—COMMITMENTS AND CONTINGENCIES

Indemnification obligations

The Company is a party to a variety of agreements pursuant to which it may be obligated to indemnify the other party with respect to certain matters. Typically, these obligations arise in the context of contracts entered into by the Company, under which the Company agrees to hold the other party harmless against losses arising from a breach of representations and covenants related to such matters as title to assets sold and certain intellectual property rights. In each of these circumstances, payment by the Company is conditioned on the other party making a claim pursuant to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party’s claims. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by it under these agreements.

It is not possible to predict the maximum potential amount of future payments that may be required under these or similar agreements due to the conditional nature of the Company’s obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments made by the Company under these agreements have not had a material effect on its business, financial condition, cash flows or results of operations.

18

Product warranties

The Company warrants its products to be free of defects generally for a period of three years. The Company estimates its warranty costs based on historical warranty claim experience and includes such costs in cost of revenues. Warranty costs and the accrued warranty liability were not material as of December 31, 2020 and March 31, 2020 and for the three months ended December 31, 2020 or 2019.

NOTE 10—STOCK-BASED COMPENSATION

As of December 31, 2020, 1,576,722 shares of common stock were available for grant under the Company’s 2016 Equity Incentive Plan.

The following table summarizes the Company’s stock option activities for the nine months ended December 31, 2020:

			Weighted
		Number of Shares	Average	Weighted
	Shares	Underlying	Remaining	Average
	Available for	Options	Contractual	Exercise		Intrinsic
	Grant	Outstanding	Life (Years)	Price		Value
Balance at March 31, 2020	2,522,314	8,135,791		$	6.17
Granted	(989,842)	989,842		$	6.14
Exercised	—	(443,190)		$	5.94	$	583,645
Forfeited	44,250	(161,833)		$	7.01
Balance at December 31, 2020	1,576,722	8,520,610	5.57	$	6.17
Options vested and exercisable		5,497,662	4.02	$	5.70	$	9,735,923
Options vested and expected to vest		8,440,795	5.54	$	6.16	$	11,522,386

The weighted average fair value per underlying share of options granted during the three months ended December 31, 2020 and 2019 was $2.51 and $2.66, respectively, and $2.39 and $2.84 for the nine months ended December 31, 2020 and 2019, respectively.

Options outstanding by exercise price at December 31, 2020 were as follows:

				Number of	Options Outstanding			Options Exercisable
				Shares	Weighted		Weighted Average		Weighted
				Underlying	Average		Remaining	Number	Average
				Options	Exercise		Contractual	Vested and	Exercise
Exercise Price				Outstanding	Price		Life (Years)	Exercisable	Price
$	3.40	-	4.81	888,007	$	4.06	3.32	888,007	$	4.06
$	4.90	-	4.99	1,255,826	$	4.97	4.48	1,255,826	$	4.97
$	5.13	-	5.59	910,509	$	5.32	3.68	910,509	$	5.32
$	5.69	-	5.83	854,567	$	5.81	7.36	270,874	$	5.76
$	5.91	-	6.45	933,860	$	6.17	6.18	568,329	$	6.20
$	6.54	-	6.70	1,100,140	$	6.65	5.15	555,193	$	6.60
$	6.86	-	7.26	1,042,797	$	7.08	5.55	563,773	$	6.95
$	7.40	-	8.09	812,431	$	7.79	8.27	330,598	$	7.79
$	8.30			613,893	$	8.30	8.58	45,973	$	8.30
$	9.20			108,580	$	9.20	0.08	108,580	$	9.20
				8,520,610	$	6.17	5.57	5,497,662	$	5.70

19

The following table summarizes stock-based compensation expense by line item in the Condensed Consolidated Statements of Operations, all relating to employee stock plans:

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
				(In Thousands)
Cost of revenues	$	88	$	77	$	260	$	184
Research and development		343		347		1,109		1,143
Selling, general and administrative		262		205		732		595
Total	$	693	$	629	$	2,101	$	1,922

As stock-based compensation expense recognized in the Condensed Consolidated Statement of Operations is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures in accordance with authoritative guidance.  The Company estimates forfeitures at the time of grant and revises the original estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

No tax benefit related to stock-based compensation was recognized in the nine months ended December 31, 2020 due to a full valuation allowance. There were no windfall tax benefits realized from exercised stock options in either of these periods. Compensation cost capitalized within inventory at December 31, 2020 was immaterial. As of December 31, 2020, the Company’s total unrecognized compensation cost was $5.2 million, which will be recognized over a weighted average period of 2.09 years.  The Company calculated the fair value of stock-based awards in the periods presented using the Black-Scholes option pricing model and the following weighted average assumptions:

	Three Months Ended December 31,						Nine Months Ended December 31,
	2020			2019					2020				2019
Stock Option Plans:
Risk-free interest rate		0.38	%		1.66	%	0.22	-	0.38	%	1.66	-	2.30	%
Expected life (in years)		5.00			5.00				5.00				5.00
Volatility		47.1	%		36.5	%	41.9	-	47.1	%	36.5	-	37.3	%
Dividend yield		—	%		—	%			—	%			—	%
Employee Stock Purchase Plan:
Risk-free interest rate		0.12	%		1.58	%	0.12	-	0.15	%	1.58	-	2.43	%
Expected life (in years)		0.50			0.50				0.50				0.50
Volatility		68.6	%		33.5	%	67.1	-	68.6	%	33.5	-	43.1	%
Dividend yield		—	%		—	%			—	%			—	%

NOTE 11—RELATED PARTY TRANSACTION

The Company incurred non-recurring engineering service expense of approximately $326,000 during the nine months ended December 31, 2020 from Wistron Neweb Corp (“WNC”) in connection with the manufacturing of single-APU PCIe boards, to be used in the Company’s in-place associative computing product. Haydn Hsieh, a member of the Company’s board of directors, is the Chairman and Chief Strategy Officer of WNC. The amount owed to WNC, of $243,000 at December 31, 2020, is included in accounts payable in the Condensed Consolidated Balance Sheets.

NOTE 12—SEGMENT AND GEOGRAPHIC INFORMATION

Based on its operating management and financial reporting structure, the Company has determined that it has one reportable business segment: the design, development and sale of integrated circuits.

20

The following is a summary of net revenues by geographic area based on the location to which product is shipped:

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands)
United States	$	3,550	$	4,408	$	9,363	$	12,794
China		760		1,221		1,762		4,590
Singapore		772		766		2,608		5,538
Netherlands		951		417		4,083		5,169
Germany		615		2,958		1,653		5,870
Rest of the world		115		279		574		847
	$	6,763	$	10,049	$	20,043	$	34,808

All sales are denominated in United States dollars.

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q, and in particular the following Management’s Discussion and Analysis of Financial Condition and Results of Operations, includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  These forward-looking statements involve risks and uncertainties.  Forward-looking statements are identified by words such as “anticipates,” “believes,” “expects,” “intends,” “may,” “will,” and other similar expressions.  In addition, any statements which refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements.  Actual results could differ materially from those projected in the forward-looking statements as a result of a number of factors, including those set forth in this report under “Risk Factors,” those described elsewhere in this report, and those described in our other reports filed with the Securities and Exchange Commission (“SEC”).  We caution you not to place undue reliance on these forward-looking statements, which speak only as of the date of this report, and we undertake no obligation to update these forward-looking statements after the filing of this report. You are urged to review carefully and consider our various disclosures in this report and in our other reports publicly disclosed or filed with the SEC that attempt to advise you of the risks and factors that may affect our business.

Overview

We are a fabless semiconductor company that designs, develops and markets static random access memories, or SRAMs, that operate at speeds of less than 10 nanoseconds, which we refer to as Very Fast SRAMs, primarily for the networking and telecommunications markets. We are subject to the highly cyclical nature of the semiconductor industry, which has experienced significant fluctuations, often in connection with fluctuations in demand for the products in which semiconductor devices are used. Our revenues have been substantially impacted by significant fluctuations in sales to our largest customer, Nokia. We expect that future direct and indirect sales to Nokia will continue to fluctuate significantly on a quarterly basis. The networking and telecommunications market has accounted for a significant portion of our net revenues in the past and has declined during the past several years and is expected to continue to decline. However, with no debt, substantial liquidity and a history of positive cash flows from operations, we believe we are in a better financial position than many other companies of our size.

On March 11, 2020, the World Health Organization announced that COVID-19, a respiratory illness caused by a novel coronavirus, is a pandemic. COVID-19 has spread to many of the countries in which we, our customers, our suppliers and our other business partners conduct business. Governments in affected regions have implemented, and may continue to implement, safety precautions which include quarantines, travel restrictions, business closures, cancellations of public gatherings and other measures as they deem necessary. Many organizations and individuals, including the Company and our employees, are taking additional steps to avoid or reduce infection, including limiting travel and working from home. These measures are disrupting normal business operations both in and outside of affected areas and have had significant negative impacts on businesses and financial markets worldwide.

21

While expected to be temporary, these disruptions have negatively impacted our revenue, results of operations, financial condition, and liquidity during fiscal year 2021.

We continue to monitor our operations and government recommendations and have made modifications to our normal operations because of the COVID-19 global pandemic. We have instituted many preventative measures and are regularly evaluating those measures and others as we continue to better understand our current and future operating environment. Except for our employees located in Taiwan, the majority of our employees are working from home around the world, and productivity remains high. We have maintained a substantial portion of our manufacturing operational capacity at our primary manufacturing support facility located in Hsin Chu, Taiwan where our suppliers are located and all of our products are manufactured. Since the outbreak of COVID-19, aside from the lengthening of lead times for wafers and assembly services, we have experienced minimal impact on our manufacturing operations in Taiwan. Final testing of our product is conducted in house. Shipping and receiving operations at our United States headquarters are being maintained by a skeleton crew with minimal impact. Our revenues have been and are expected to continue to be impacted by changes in customer buying patterns and communication limitations related to shelter in place restrictions that require a significant number of our customer contacts to work from home. Our results for the quarter and nine month periods ended December 31, 2020 demonstrate the challenges that we are facing during the COVID-19 global pandemic, which has restricted the activities of our sales force and distributors, reduced customer demand and caused the postponement of investment in certain customer sectors. These challenges are also impacting us as we enter new markets and engage with target customers. Industry conferences and on-site training workshops, which are typically used for building a sales pipeline, are unavailable due to COVID-19 related restrictions. We have adapted our sales strategies for the COVID-19 environment, where we cannot do face-to-face meetings and conduct secure meetings with government and defense customers, but we are still not operating at an optimal level.

The disruption to the marketplace resulting from the COVID-19 global pandemic that we continue to experience is unlike anything we have ever had to deal with. While we continue to monitor the business metrics that we have historically used to predict our financial performance, we are uncertain as to whether these metrics will operate consistently with our historical experience.

As of December 31, 2020, we had cash, cash equivalents, and short-term and long-term investments of $62.4 million, with no debt. We have a team in-place with tremendous depth and breadth of experience and knowledge, with a legacy business that is providing an ongoing source of funding for the development of new product lines. We have a strong balance sheet and liquidity position that we anticipate will provide financial flexibility and security in the current environment of economic uncertainty with no current expectations of additional cash infusions required. Generally, our primary source of liquidity is cash generated from operating activities. Our level of cash and cash flows from operations have historically been sufficient to meet our operating and capital needs. We believe that during the next 12 months the COVID-19 global pandemic could impact general economic activity and demand in our end markets. Although we cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it is expected to have an adverse effect on our results of operations, financial position, and liquidity in fiscal year 2021 and into fiscal year 2022.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted to provide emergency economic stimulus in response to the COVID-19 global pandemic. The CARES Act includes direct financial assistance to Americans in the form of one-time payments to individuals, aid to small businesses in the form of loans and grants, and other efforts to stabilize the U.S. economy and keep Americans employed. We have not filed, and currently do not intend to file, for funding related to the CARES Act due to our strong balance sheet and liquidity position with $62.4 million in cash and cash equivalents, short-term investments and long-term investments and no debt outstanding as of December 31, 2020. Also included in the CARES Act are numerous income tax provisions including changes to the net operating loss rules that we believe will not have a significant impact on us.

Revenues.    Our revenues are derived primarily from sales of our Very Fast SRAM products. Sales to networking and telecommunications OEMs accounted for 50% to 55% of our net revenues during our last three fiscal years. We also sell our products to OEMs that manufacture products for military and aerospace applications such as radar and guidance systems, missiles and satellites, for professional audio applications such as sound mixing systems, for test and measurement applications such as high-speed testers, for automotive applications such as smart

22

cruise control and voice recognition systems, and for medical applications such as ultrasound and CAT scan equipment.

As is typical in the semiconductor industry, the selling prices of our products generally decline over the life of the product. Our ability to increase net revenues, therefore, is dependent upon our ability to increase unit sales volumes of existing products and to introduce and sell new products with higher average selling prices in quantities sufficient to compensate for the anticipated declines in selling prices of our more mature products. Although we expect the average selling prices of individual products to decline over time, we believe that, over the next several quarters, our overall average selling prices will increase due to a continuing shift in product mix to a higher percentage of higher price, higher density products. Our ability to increase unit sales volumes is dependent primarily upon increases in customer demand but, particularly in periods of increasing demand, can also be affected by our ability to increase production through the availability of increased wafer fabrication capacity from Taiwan Semiconductor Manufacturing Company, or TSMC, our wafer supplier, and our ability to increase the number of good integrated circuit die produced from each wafer through die size reductions and yield enhancement activities.

We may experience fluctuations in quarterly net revenues for a number of reasons. Historically, orders on hand at the beginning of each quarter are insufficient to meet our revenue objectives for that quarter and are generally cancelable up to 30 days prior to scheduled delivery. Accordingly, we depend on obtaining and shipping orders in the same quarter to achieve our revenue objectives. In addition, the timing of product releases, purchase orders and product availability could result in significant product shipments at the end of a quarter. Failure to ship these products by the end of the quarter may adversely affect our operating results. Furthermore, our customers may delay scheduled delivery dates and/or cancel orders within specified timeframes without significant penalty.

We sell our products through our direct sales force, international and domestic sales representatives and distributors. Our revenues have been and are expected to continue to be impacted by changes in customer buying patterns and communication limitations related to COVID-19 shelter in place restrictions that require a significant number of our customer contacts to work from home. The majority of our customer contracts, which may be in the form of purchase orders, contracts or purchase agreements, contain performance obligations for delivery of agreed upon products. Delivery of all performance obligations contained within a contract with a customer typically occurs at the same time (or within the same accounting period). Transfer of control typically occurs at the time of shipment or at the time the product is pulled from consignment as that is the point at which delivery has occurred, title and the risks and rewards of ownership have passed to the customer, and we have a right to payment. Thus, we will generally recognize revenue upon shipment of the product. Sales to consignment warehouses, who purchase products from us for use by contract manufacturers, are recorded upon delivery to the contract manufacturer.

Nokia was our largest customer in fiscal 2020, 2019 and 2018. Nokia purchases products directly from us and through contract manufacturers and distributors. Based on information provided to us by its contract manufacturers and our distributors, purchases by Nokia represented approximately 40%, 38%, 45% and 36% of our net revenues in the nine months ended December 31, 2020 and in fiscal 2020, 2019 and 2018, respectively. Our revenues have been substantially impacted by significant fluctuations in sales to Nokia, and we expect that future direct and indirect sales to Nokia will continue to fluctuate substantially on a quarterly basis and that such fluctuations may significantly affect our operating results in future periods. To our knowledge, none of our other OEM customers accounted for more than 10% of our net revenues in the nine months ended December 31, 2020 and in fiscal 2020, 2019 or 2018.

Cost of Revenues.    Our cost of revenues consists primarily of wafer fabrication costs, wafer sort, assembly, test and burn-in expenses, the amortized cost of production mask sets, stock-based compensation and the cost of materials and overhead from operations. All of our wafer manufacturing and assembly operations, and a significant portion of our wafer sort testing operations, are outsourced. Accordingly, most of our cost of revenues consists of payments to TSMC and independent assembly and test houses. Because we do not have long-term, fixed-price supply contracts, our wafer fabrication and other outsourced manufacturing costs are subject to the cyclical fluctuations in demand for semiconductors. Cost of revenues also includes expenses related to supply chain management, quality assurance, and final product testing and documentation control activities conducted at our headquarters in Sunnyvale, California and our branch operations in Taiwan.

23

Gross Profit.    Our gross profit margins vary among our products and are generally greater on our higher density products and, within a particular density, greater on our higher speed and industrial temperature products. We expect that our overall gross margins will fluctuate from period to period as a result of shifts in product mix, changes in average selling prices and our ability to control our cost of revenues, including costs associated with outsourced wafer fabrication and product assembly and testing.

Research and Development Expenses.    Research and development expenses consist primarily of salaries and related expenses for design engineers and other technical personnel, the cost of developing prototypes, stock-based compensation and fees paid to consultants. We charge all research and development expenses to operations as incurred. We charge mask costs used in production to cost of revenues over a 12-month period. However, we charge costs related to pre-production mask sets, which are not used in production, to research and development expenses at the time they are incurred. These charges often arise as we transition to new process technologies and, accordingly, can cause research and development expenses to fluctuate on a quarterly basis. We believe that continued investment in research and development is critical to our long-term success, and we expect to continue to devote significant resources to product development activities. In particular, we are devoting substantial resources to the development of a new category of in-place associative computing products. Accordingly, we expect that our research and development expenses will continue to be substantial in future periods and may lead to operating losses in some periods. Such expenses as a percentage of net revenues may fluctuate from period to period.

Selling, General and Administrative Expenses.     Selling, general and administrative expenses consist primarily of commissions paid to independent sales representatives, salaries, stock-based compensation and related expenses for personnel engaged in sales, marketing, administrative, finance and human resources activities, professional fees, costs associated with the promotion of our products and other corporate expenses. We expect that our sales and marketing expenses will increase in absolute dollars in future periods if we are able to grow and expand our sales force but that, to the extent our revenues increase in future periods, these expenses will generally decline as a percentage of net revenues. We also expect that, in support of any future growth that we are able to achieve, general and administrative expenses will generally increase in absolute dollars.

Results of Operations

The following table sets forth statement of operations data as a percentage of net revenues for the periods indicated:

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
Net revenues	100.0	%	100.0	%	100.0	%	100.0	%
Cost of revenues	52.7		39.8		53.3		40.1
Gross profit	47.3		60.2		46.7		59.9
Operating expenses:
Research and development	84.8		81.7		85.9		56.4
Selling, general and administrative	38.7		25.7		40.6		23.3
Total operating expenses	123.5		107.4		126.5		79.7
Loss from operations	(76.2)		(47.2)		(79.8)		(19.8)
Interest and other income, net	0.4		2.1		0.6		1.6
Loss before income taxes	(75.8)		(45.1)		(79.2)		(18.2)
Provision for income taxes	1.3		0.9		3.2		0.5
Net loss	(77.1)		(46.0)		(82.4)		(18.7)

Net Revenues. Net revenues decreased by 32.7% from $10.0 million in the three months ended December 31, 2019 to $6.8 million in the three months ended December 31, 2020 and by 42.4% from $34.8 million in the nine months ended December 31, 2019 to $20.0 million in the nine months ended December 31, 2020.

Net revenues in the three and nine month periods ended December 31, 2020 were impacted by the COVID-19 global pandemic. Our net revenues in the current fiscal year demonstrate the challenges that we are facing during

24

the COVID-19 global pandemic, which has restricted the activities of our sales force and distributors, reduced customer demand and caused the postponement of investment in certain customer sectors. These challenges are also impacting us as we enter new markets and engage with target customers. Industry conferences and on-site training workshops, which are typically used for building a sales pipeline, are unavailable due to COVID-19 related restrictions. We have adapted our sales strategies for the COVID-19 environment as there are limitations with both in-person and virtual meetings, particularly, government and defense customers with regards to secure teleconferencing. However, we are still not operating at an optimal level.

The overall average selling price of all units shipped in the quarter ended December 31, 2020 decreased by 1.0% compared to the quarter ended December 31, 2019 and decreased by 7.3% in the nine months ended December 31, 2020 compared to the nine months ended December 31, 2019. The changes in the average selling price in each fiscal 2021 period were due to changes in product mix, as we sold less higher density, higher average selling price products in the fiscal 2021 periods compared to the prior fiscal year periods. Direct and indirect sales to Nokia, currently our largest customer, increased from $2.6 million in the three months ended December 31, 2019 to $2.8 million in the three months ended December 31, 2020 and decreased from $13.9 million in the nine months ended December 31, 2019 to $8.1 million in the nine months ended December 31, 2020. Shipments of our SigmaQuad product line accounted for 62.0% of total shipments in the three months ended December 31, 2019 and in the three months ended December 31, 2020 and 64.7% of total shipments in the nine months ended December 31, 2019 compared to 58.1% of total shipments in the nine months ended December 31, 2020. The changes in SigmaQuad shipments were primarily due to the changes in sales to Nokia discussed above.

Cost of Revenues. Cost of revenues decreased by 10.9% from $4.0 million in the three months ended December 31, 2019 to $3.6 million in the three months ended December 31, 2020 and decreased by 23.4% from $13.9 million in the nine months ended December 31, 2019 to $10.7 million in the nine months ended December 31, 2020. Cost of revenues included a provision for excess and obsolete inventories of $260,000 in the nine months ended December 31, 2019 compared to $327,000 in the nine months ended December 31, 2020. Cost of revenues included stock-based compensation expense of $77,000 and $88,000 for the three months ended December 31, 2019 and 2020, respectively, and $184,000 and $260,000 for the nine months ended December 31, 2019 and 2020, respectively.

Gross Profit. Gross profit decreased by 47.1% from $6.0 million in the three months ended December 31, 2019 to $3.2 million in the three months ended December 31, 2020 and decreased by 55.1% from $20.9 million in the nine months ended December 31, 2019 to $9.4 million in the nine months ended December 31, 2020.

Gross margin decreased from 60.2% in the three months ended December 31, 2019 to 47.3% in the three months ended December 31, 2020 and decreased from 59.9% in the nine months ended December 31, 2019 to 46.7% in the nine months ended December 31, 2020. The change in gross profit in each period is primarily related to the changes in net revenues discussed above. The changes in gross margin are primarily related to changes in the mix of products and customers and changes in the level of charges for inventory reserves booked in each period.

Research and Development Expenses. Research and development expenses decreased by 30.1% from $8.2 million in the three months ended December 31, 2019 to $5.7 million in the three months ended December 31, 2020. The decrease in research and development spending was primarily related to a decrease of $2.7 million for purchased intellectual property partially offset by a lesser increase in payroll related expenses. Research and development expenses included stock-based compensation expense of $347,000 and $343,000 for the three months ended December 31, 2019 and 2020, respectively. Research and development expenses decreased 12.3% from $19.6 million in the nine months ended December 31, 2019 to $17.2 million in the nine months ended December 31, 2020. The decrease in research and development spending was primarily related to a decrease of $2.7 million for purchased intellectual property and a lesser decrease in consultants expenses partially offset by lesser increases in payroll related expenses, patent related legal fees and software maintenance expenses. Research and development expenses included stock-based compensation expense of $1.1 million for the nine months ended December 31, 2019 and 2020.

Selling, General and Administrative Expenses. Selling, general and administrative expenses were unchanged at $2.6 million in the three months ended December 31, 2019 and in the three months ended December 31, 2020. A decrease of $179,000 for independent sales representatives commissions and a lesser decrease in travel

25

expenses was primarily offset by an increase in professional fees. Selling, general and administrative expenses included stock-based compensation expense of $205,000 and $262,000 for the three months ended December 31, 2019 and 2020, respectively. Selling, general and administrative expenses were unchanged at $8.1 million in the nine months ended December 31, 2019 and in the nine months ended December 31, 2020. Decreases in independent sales representative commissions of $466,000 and $131,000 in travel expenses were primarily offset by increases in professional fees, payroll related expenses and stock-based compensation expense. Selling, general and administrative expenses included stock-based compensation expense of $595,000 and $732,000 for the nine months ended December 31, 2019 and 2020, respectively.

Interest Income and Other Income, Net. Interest and other income, net decreased 87.9% from income of $207,000 in the three months ended December 31, 2019 to $25,000 in the three months ended December 31, 2020. Interest income decreased by $139,000 primarily due to lower interest rates received on our cash and short-term and long-term investments. Foreign exchange gains were $18,000 for the three months ended December 31, 2019 compared to losses of $25,000 for the three months ended December 31, 2020. The exchange gains and losses in each period were related to our Taiwan branch operations and our operations in Israel. Interest and other income, net decreased 79.6% from income of $564,000 in the nine months ended December 31, 2019 to $115,000 in the nine months ended December 31, 2020. Interest income decreased by $366,000 primarily due to lower interest rates received on our cash and short-term and long-term investments. We had a foreign exchange loss of $46,000 for the nine months ended December 31, 2019 compared to $129,000 for the nine months ended December 31, 2020. The exchange losses in each period were related to our Taiwan branch operations and our operations in Israel.

Provision for Income Taxes. The provision for income taxes increased 7.1% from $84,000 in the three months ended December 31, 2019 to $90,000 in the three months ended December 31, 2020 and increased 251.1% from $182,000 in the nine months ended December 31, 2019 to $639,000 in the nine months ended December 31, 2020. This change for the nine month period was primarily due to the settlement of an income tax audit in Israel during the quarter ended June 30, 2020 for fiscal years 2016 through fiscal 2019 which resulted in a discrete tax provision of $479,000, and to a lesser extent due to fluctuations in the relative mix of income among our operating jurisdictions.

Net Loss. Net loss was $4.6 million in the three months ended December 31, 2019 compared $5.2 million in the three months ended December 31, 2020 and was $6.5 million in the nine months ended December 31, 2019 compared to $16.5 million in the nine months ended December 31, 2020. These fluctuations were primarily due to the changes in net revenues, gross profit and operating expenses discussed above.

Liquidity and Capital Resources

As of December 31, 2020, our principal sources of liquidity were cash, cash equivalents and short-term investments of $52.3 million compared to $66.6 million as of March 31, 2020.

Net cash used in operating activities was $11.4 million for the nine months ended December 31, 2020 compared to $1.2 million for the nine months ended December 31, 2019. The primary uses of cash in the nine months ended December 31, 2020 was the net loss of $16.5 million and a reduction in accrued expenses and other liabilities of $1.7 million. The reduction in accrued expenses and other liabilities was primarily related to the payment of fiscal 2020 year-end accruals for purchased intellectual property. Primary sources of cash in the nine months ended December 31, 2020 were a reduction in accounts receivable of $2.3 million, non-cash items including stock-based compensation of $2.1 million and depreciation and amortization expenses of $962,000 and an increase in accounts payable of $1.2 million. The decrease in accounts receivable was primarily due to the decrease in shipments in the quarter ended December 31, 2020 compared to the quarter ended March 31, 2020.

The primary uses of cash in the nine months ended December 31, 2019 was the net loss of $6.5 million, an increase of $1.1 million in prepaid expenses and other assets and a reduction in accounts payable of $728,000.

Primary sources of cash in the nine months ended December 31, 2019 were non-cash items including stock-based compensation of $1.9 million and depreciation and amortization expenses of $1.1 million and a reduction in accounts receivable of $2.0 million. The decrease in accounts receivable was primarily due to the decrease in net revenues in the quarter ended December 31, 2019 compared to the quarter ended March 31, 2019.

26

Net cash used in investing activities was $381,000 in the nine months ended December 31, 2020 compared to net cash provided by investing activities of $3.5 million in the nine months ended December 31, 2019.

Investment activities in the nine months ended December 31, 2020 primarily consisted of the purchase of certificates of deposit, agency bonds and supranational obligations of $17.5 million, partially offset by the maturity of certificates of deposit and agency bonds of $17.3 million. Investment activities in the nine months ended December 31, 2019 primarily consisted of the maturity of certificates of deposit of $18.6 million, partially offset by the purchase of certificates of deposit and agency bonds of $15.9 million.

Net cash provided by financing activities in the nine months ended December 31, 2020 consisted of the net proceeds from the sale of common stock pursuant to our employee stock plans of $3.3 million. Net cash provided by financing activities in the nine months ended December 31, 2019 primarily consisted of the net proceeds from the sale of common stock pursuant to our employee stock plans of $3.6 million partially offset by the release of an escrow deposit related to our acquisition of MikaMonu in the amount of $428,000.

Our estimated annual effective income tax rate was approximately (3.4%) as of December 31, 2020.  

We believe that our existing balances of cash, cash equivalents and short-term investments, and cash flow expected to be generated from our future operations will be sufficient to meet our cash needs for working capital and capital expenditures for at least the next 12 months. Our future capital requirements will depend on many factors, including revenue growth, if any, that we experience, the extent to which we utilize subcontractors, the levels of inventory and accounts receivable that we maintain, the timing and extent of spending to support our product development efforts and the expansion of our sales and marketing. Additional capital may also be required for the consummation of any acquisition of businesses, products or technologies that we may undertake. We cannot assure that additional equity or debt financing, if required, will be available on terms that are acceptable or at all.

Contractual Obligations

The following table describes our contractual obligations as of December 31, 2020:

	Payments due by period (in thousands)
		Up to 1 year		1 - 3 years		3 - 5 years		More than 5 years		Total
Facilities and software leases	$	154	$	646	$	102	$	—	$	902
Wafer, software and test purchase obligations		1,536		345		—		—		1,881
	$	1,690	$	991	$	102	$	—	$	2,783

As of December 31, 2020, the current portion of our unrecognized tax benefits was $0, and the long-term portion was $326,000.

In connection with the acquisition of MikaMonu on November 23, 2015, we are required to make contingent consideration payments to the former MikaMonu shareholders conditioned upon revenue targets for products based on the MikaMonu technology. As of December 31, 2020, the accrual for potential contingent consideration was $4.0 million and is payable at various dates through December 31, 2025.

Critical Accounting Policies and Estimates

Our critical accounting policies and estimates are disclosed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

Off-Balance Sheet Arrangements

At December 31, 2020, we did not have any off-balance sheet arrangements or relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. Accordingly, we are not exposed to the type of financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

27

Recent Accounting Pronouncements

Please refer to Note 1 to our condensed consolidated financial statements appearing under Part I, Item 1 for a discussion of recent accounting pronouncements that may impact the Company.

Item 3.Quantitative and Qualitative Disclosure About Market Risk

Foreign Currency Exchange Risk. Our revenues and expenses, except those expenses related to our operations in Taiwan and in Israel, including subcontractor manufacturing expenses, are denominated in U.S. dollars. As a result, we have relatively little exposure for currency exchange risks, and foreign exchange gains and losses have been minimal to date. We do not currently enter into forward exchange contracts to hedge exposure denominated in foreign currencies or any other derivative financial instruments for trading or speculative purposes. In the future, if we feel our foreign currency exposure has increased, we may consider entering into hedging transactions to help mitigate that risk.

Interest Rate Sensitivity.  We had cash, cash equivalents, short-term investments and long-term investments totaling $62.4 million at December 31, 2020. These amounts were invested primarily in money market funds, certificates of deposit, government agency bonds and foreign government obligations. The cash, cash equivalents and short-term marketable securities are held for working capital purposes. We do not enter into investments for trading or speculative purposes. Due to the short-term nature of these investments, we believe that we do not have any material exposure to changes in the fair value of our investment portfolio as a result of changes in interest rates. We believe a hypothetical 100 basis point increase or decrease in interest rates would not materially affect the fair value of our interest-sensitive financial instruments.  Declines in interest rates, however, will reduce future investment income.

Item 4.Controls and Procedures

Management’s Evaluation of Disclosure Controls and Procedures

Based on their evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of December 31, 2020, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report for the purpose of ensuring that the information required to be disclosed by us in this report is made known to them by others on a timely basis, and that the information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in order to allow timely decisions regarding required disclosure, and that such information is recorded, processed, summarized, and reported by us within the time periods specified in the SEC's rules and instructions for Form 10-Q.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 1A. Risk Factors

Our future performance is subject to a variety of risks.  If any of the following risks actually occur, our business, financial condition and results of operations could suffer and the trading price of our common stock could decline.  Additional risks that we currently do not know about or that we currently believe to be immaterial may also impair our business operations. You should also refer to other information contained in this report, including our condensed consolidated financial statements and related notes.  The risk factors described below do not contain any material changes from those previously disclosed in Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

28

Risks Related to Our Business and Financial Condition

Unpredictable fluctuations in our operating results could cause our stock price to decline.

Our quarterly and annual revenues, expenses and operating results have varied significantly and are likely to vary in the future. For example, in the eleven fiscal quarters ended December 31, 2020, we recorded net revenues of as much as $14.7 million and as little as $6.6 million, including net revenues varying from $6.6 million to $6.8 million in the last three quarters and quarterly operating income of as much as $2.2 million and, in ten quarters, operating losses, including operating losses varying from $5.2 million to $5.7 million in the last three quarters ended December 31, 2020. We therefore believe that period-to-period comparisons of our operating results are not a good indication of our future performance, and you should not rely on them to predict our future performance or the future performance of our stock price. For the last three consecutive quarters, our net revenues were adversely impacted by the COVID-19 global pandemic.In future periods, we may not have any revenue growth, or our revenues could decline or continue to be further adversely impacted by the COVID-19 global pandemic. Furthermore, if our operating expenses exceed our expectations, our financial performance could be adversely affected. Factors that may affect periodic operating results in the future include:

●commercial acceptance of our associative computing products;

●changes in our customers' inventory management practices;

●unpredictability of the timing and size of customer orders, since most of our customers purchase our products on a purchase order basis rather than pursuant to a long-term contract;

●our ability to anticipate and conform to new industry standards;

●fluctuations in availability and costs associated with materials needed to satisfy customer requirements;

●manufacturing defects, which could cause us to incur significant warranty, support and repair costs, lose potential sales, harm our relationships with customers and result in write-downs;

●changes in our product pricing policies, including those made in response to new product announcements and pricing changes of our competitors; and

●our ability to address technology issues as they arise, improve our products' functionality and expand our product offerings.

Our expenses are, to a large extent, fixed, and we expect that these expenses will increase in the future. We will not be able to adjust our spending quickly if our revenues fall short of our expectations. If this were to occur, our operating results would be harmed. If our operating results in future quarters fall below the expectations of market analysts and investors, the price of our common stock could fall.

The COVID-19 global pandemic has caused increased stock market volatility and uncertainty in customer demand and the worldwide economy in general, and we may continue to experience decreased sales and revenues in the future. We expect such impact will in particular affect our SRAM sales and may also impact the launch of our APU product to some degree. However, the magnitude of such impact on our business and its duration is highly uncertain.

Our largest OEM customer accounts for a significant percentage of our net revenues. If this customer, or any of our other major customers, reduces the amount they purchase or stop purchasing our products, our operating results will suffer.

Nokia, our largest customer, purchases our products directly from us and through contract manufacturers and distributors. Purchases by Nokia represented approximately 40%, 38%, 45% and 36% of our net revenues in the nine months ended December 31, 2020 and in fiscal 2020, 2019 and 2018, respectively. We expect that our

29

operating results in any given period will continue to depend significantly on orders from our key OEM customers, particularly Nokia, and our future success is dependent to a large degree on the business success of this customer over which we have no control. We do not have long-term contracts with Nokia or any of our other major OEM customers, distributors or contract manufacturers that obligate them to purchase our products. We expect that future direct and indirect sales to Nokia and our other key OEM customers will continue to fluctuate significantly on a quarterly basis and that such fluctuations may substantially affect our operating results in future periods. The decline in economic activity resulting from the COVID-19 global pandemic is expected to cause a continued reduction in orders from Nokia and our other key OEM customers. If we fail to continue to sell to our key OEM customers, distributors or contract manufacturers in sufficient quantities, our business could be harmed.

The ongoing COVID-19 global pandemic may continue to adversely affect our revenues, results of operations and financial condition.

Our business is expected to continue to be materially adversely affected by global outbreak of respiratory illness caused by a novel coronavirus known as COVID-19. COVID-19 has been declared by the World Health Organization to be a “pandemic” and has spread to many of the countries in which we, our customers, our suppliers and our other business partners conduct business. National, state and local governments in affected regions have implemented, and may continue to implement, safety precautions which include quarantines, travel restrictions, business closures, cancellations of public gatherings and other measures as they deem necessary. Many organizations and individuals, including the Company and our employees, are taking additional steps to avoid or reduce infection, including limiting travel and working from home. These measures are disrupting normal business operations both in and outside of affected areas and have had significant negative impacts on businesses and financial markets worldwide.

We continue to monitor our operations and government recommendations and have made modifications to our normal operations because of the COVID-19 global pandemic. We have instituted many preventative measures and are regularly evaluating those measures and others as we continue to better understand our current and future operating environment. Except for our employees located in Taiwan, the majority of our employees are working from home around the world. We have maintained a substantial portion of our manufacturing operational capacity at our primary manufacturing support facility located in Hsin Chu, Taiwan where our suppliers are located and where all of our products are manufactured. Since the outbreak of COVID-19, aside from the lengthening of lead times for wafers and assembly services, we have experienced minimal impact on our manufacturing operations in Taiwan. Final testing of our product is conducted in house. Shipping and receiving operations at our Sunnyvale headquarters facility are being maintained by a skeleton crew with minimal impact. Our revenues have been and are expected to continue to be impacted by changes in customer buying patterns and communication limitations related to shelter in place restrictions that require a significant number of our customer contacts to work from home.

We have experienced, and expect to continue to experience, a number of adverse impacts as a result of the COVID-19 global pandemic, including reductions in demand for our products, delays and cancellations of orders, difficulties in obtaining raw materials and components, shortages of labor to manufacture products, inefficiencies caused by remote worker’s difficulties in performing their normal work outputs, closures of the facilities of some of our suppliers and customers, delays in shipments and delays in collecting accounts receivable. Although we cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it is expected to have an adverse effect on our results of operations, financial position, and liquidity during fiscal year 2021 and into fiscal year 2022. This includes results from new information that may emerge concerning COVID-19 and any actions taken to contain or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. We have made estimates of the impact of COVID-19 within our financial statements and there may be changes to those estimates in future periods.

The disruption to the marketplace resulting from the COVID-19 global pandemic that we continue to experience is unlike anything we have ever had to deal with. While we continue to monitor the business metrics that we have historically used to predict our financial performance, we are uncertain as to whether these metrics will operate consistently with our historical experience.

Disruptions in the capital markets as a result of the COVID-19 global pandemic may also adversely affect our ability to obtain additional liquidity should the impacts of the global pandemic continue for a prolonged period.

30

We have incurred significant losses and may incur losses in the future.

We have incurred significant losses. We incurred net losses of $10.3 million and $4.5 million during fiscal 2020 and 2018, respectively, and a net loss of $16.5 million during the nine months ended December 31, 2020. There can be no assurance that our Very Fast SRAMs will continue to receive broad market acceptance, that our new product development initiatives will be successful or that we will be able to achieve sustained revenue growth or profitability.

We depend upon the sale of our Very Fast SRAMs for most of our revenues, and a downturn in demand for these products could significantly reduce our revenues and harm our business.

We derive most of our revenues from the sale of Very Fast SRAMs, and we expect that sales of these products will represent the substantial majority of our revenues for the foreseeable future. Our business depends in large part upon continued demand for our products in the markets we currently serve, which could continue to be adversely impacted by the COVID-19 global pandemic, and adoption of our products in new markets. Market adoption will be dependent upon our ability to increase customer awareness of the benefits of our products and to prove their high-performance and cost-effectiveness. We may not be able to sustain or increase our revenues from sales of our products, particularly if the networking and telecommunications markets were to experience another significant downturn in the future. Any decrease in revenues from sales of our products could harm our business more than it would if we offered a more diversified line of products.

Our future success is substantially dependent on the successful development of new in-place associative computing products which entails significant risks.

Since 2015, our principal strategic objective has been the development of a new category of in-place associative computing products. We have devoted, and are continuing to devote, substantial efforts and resources to this development effort. This ongoing project involves the commercialization of new, cutting-edge technology, will require a substantial effort during fiscal 2021 and beyond and will be subject to significant risks. In addition to the typical risks associated with the development of technologically advanced products (as further detailed in the next paragraph), this project will be subject to enhanced risks of technological problems related to the development of an entirely new category of products, substantial risks of delays or unanticipated costs that may be encountered, and risks associated with the establishment of entirely new markets and customer relationships. The establishment of new customer relationships and selling our in-place associative computing products to such new customers will be a significant undertaking that will require us to invest heavily in our sales team, enter into new channel partner relationships, expand our marketing activities and change the focus of our business and operations. Our inability to successfully conclude this major development effort and establish a market for the products we hope to develop would have a material adverse effect on our future financial and business success, including our prospects for increased revenues. Additionally, if we are unable to meet the expectations of market analysts and investors with respect to this major development effort, then the price of our common stock could fall.

If we do not successfully develop new products to respond to rapid market changes due to changing technology and evolving industry standards, particularly in the networking and telecommunications markets, our business will be harmed.

If we fail to offer technologically advanced products and respond to technological advances and emerging standards, we may not generate sufficient revenues to offset our development costs and other expenses, which will hurt our business. The development of new or enhanced products is a complex and uncertain process that requires the accurate anticipation of technological and market trends. In particular, the networking and telecommunications markets are rapidly evolving and new standards are emerging. We are vulnerable to advances in technology by competitors, including new SRAM architectures, new forms of DRAM and the emergence of new memory technologies that could enable the development of products that feature higher performance or lower cost. We may experience development, marketing and other technological difficulties that may delay or limit our ability to respond to technological changes, evolving industry standards, competitive developments or end-user requirements. For example, because we have limited experience developing integrated circuits, or IC, products other than Very Fast SRAMs, our efforts to introduce new products may not be successful and our business may suffer. Other challenges that we face include:

31

●our products may become obsolete upon the introduction of alternative technologies;

●we may incur substantial costs if we need to modify our products to respond to these alternative technologies;

●we may not have sufficient resources to develop or acquire new technologies or to introduce new products capable of competing with future technologies;

●new products that we develop may not successfully integrate with our end-users’ products into which they are incorporated;

●we may be unable to develop new products that incorporate emerging industry standards;

●we may be unable to develop or acquire the rights to use the intellectual property necessary to implement new technologies; and

●when introducing new or enhanced products, we may be unable to manage effectively the transition from older products.

We are subject to the highly cyclical nature of the networking and telecommunications markets.

Our products are incorporated into routers, switches, wireless local area network infrastructure equipment, wireless base stations and network access equipment used in the highly cyclical networking and telecommunications markets. We expect that the networking and telecommunications markets will continue to be highly cyclical, characterized by periods of rapid growth and contraction. Our business and our operating results are likely to fluctuate, perhaps quite severely, as a result of this cyclicality.

The market for Very Fast SRAMs is highly competitive.

The market for Very Fast SRAMs, which are used primarily in networking and telecommunications equipment, is characterized by price erosion, rapid technological change, cyclical market patterns and intense foreign and domestic competition. Several of our competitors offer a broad array of memory products and have greater financial, technical, marketing, distribution and other resources than we have. Some of our competitors maintain their own semiconductor fabrication facilities, which may provide them with capacity, cost and technical advantages over us. We cannot assure you that we will be able to compete successfully against any of these competitors. Our ability to compete successfully in this market depends on factors both within and outside of our control, including:

●real or perceived imbalances in supply and demand of Very Fast SRAMs;

●the rate at which OEMs incorporate our products into their systems;

●the success of our customers’ products;

●our ability to develop and market new products; and

●the supply and cost of wafers.

In addition, we are vulnerable to advances in technology by competitors, including new SRAM architectures and new forms of DRAM, or the emergence of new memory technologies that could enable the development of products that feature higher performance, lower cost or lower power capabilities. Additionally, the trend toward incorporating SRAM into other chips in the networking and telecommunications markets has the potential to reduce future demand for Very Fast SRAM products. There can be no assurance that we will be able to

32

compete successfully in the future. Our failure to compete successfully in these or other areas could harm our business.

We are dependent on a number of single source suppliers, and if we fail to obtain adequate supplies, our business will be harmed and our prospects for growth will be curtailed.

We currently purchase several key components used in the manufacture of our products from single sources and are dependent upon supply from these sources to meet our needs. If any of these suppliers cannot provide components on a timely basis, at the same price or at all, our ability to manufacture our products will be constrained and our business will suffer. For example, due to the COVID-19 global pandemic, we could see additional disruptions in our supply chain beyond the longer lead-times for the purchase of wafers and assembly services that we are currently experiencing. Most significantly, we obtain wafers for our Very Fast SRAM and APU products from a single foundry, TSMC, and most of them are packaged at ASE.  If we are unable to obtain an adequate supply of wafers from TSMC or find alternative sources in a timely manner, we will be unable to fulfill our customer orders and our operating results will be harmed. We do not have supply agreements with TSMC, ASE or any of our other independent assembly and test suppliers, and instead obtain manufacturing services and products from these suppliers on a purchase-order basis. Our suppliers, including TSMC, have no obligation to supply products or services to us for any specific product, in any specific quantity, at any specific price or for any specific time period. As a result, the loss or failure to perform by any of these suppliers could adversely affect our business and operating results.

Should any of our single source suppliers experience manufacturing failures or yield shortfalls, be disrupted by the COVID-19 global pandemic, natural disaster or political instability, choose to prioritize capacity or inventory for other uses or reduce or eliminate deliveries to us for any other reason, we likely will not be able to enforce fulfillment of any delivery commitments and we would have to identify and qualify acceptable replacements from alternative sources of supply. In particular, if TSMC is unable to supply us with sufficient quantities of wafers to meet all of our requirements, we would have to allocate our products among our customers, which would constrain our growth and might cause some of them to seek alternative sources of supply. Since the manufacturing of wafers and other components is extremely complex, the process of qualifying new foundries and suppliers is a lengthy process and there is no assurance that we would be able to find and qualify another supplier without materially adversely affecting our business, financial condition and results of operations.

We rely heavily on distributors and our success depends on our ability to develop and manage our indirect distribution channels.

A significant percentage of our sales are made to distributors and to contract manufacturers who incorporate our products into end products for OEMs. For example, in the nine months ended December 31, 2020 and in fiscal 2020, 2019 and 2018, our largest distributor Avnet Logistics accounted for 31.0%, 34.3%, 31.3% and 35.3%, respectively, of our net revenues. Avnet Logistics and our other existing distributors may choose to devote greater resources to marketing and supporting the products of other companies. Since we sell through multiple channels and distribution networks, we may have to resolve potential conflicts between these channels. For example, these conflicts may result from the different discount levels offered by multiple channel distributors to their customers or, potentially, from our direct sales force targeting the same equipment manufacturer accounts as our indirect channel distributors. These conflicts may harm our business or reputation.

Because we outsource our wafer manufacturing and independent wafer foundry capacity is limited, we may be required to enter into costly long-term supply arrangements to secure foundry capacity.

We do not have a long-term supply agreement with TSMC, but instead obtain our wafers on a purchase order basis. In order to secure future wafer supply from TSMC or from other independent foundries, we may be required to enter into various arrangements with them, which could include:

●contracts that commit us to purchase specified quantities of wafers over extended periods;

●investments in and joint ventures with the foundries; or

33

●non-refundable deposits with or prepayments or loans to foundries in exchange for capacity commitments.

We may not be able to make any of these arrangements in a timely fashion or at all, and these arrangements, if any, may not be on terms favorable to us. Moreover, even if we are able to secure independent foundry capacity, we may be obligated to use all of that capacity or incur penalties. These penalties may be expensive and could harm our financial results.

If we are unable to offset increased wafer fabrication and assembly costs by increasing the average selling prices of our products, our gross margins will suffer.

If there is a significant upturn in the demand for the manufacturing and assembly of semiconductor products as has incurred in recent months as a result of the COVID-19 global pandemic, the available supply of wafers and packaging services may be limited. As a result, we could be required to obtain additional manufacturing and assembly capacity in order to meet increased demand. Securing additional manufacturing and assembly capacity may cause our wafer fabrication and assembly costs to increase. If we are unable to offset these increased costs by increasing the average selling prices of our products, our gross margins will decline.

The average selling prices of our products are expected to decline, and if we are unable to offset these declines, our operating results will suffer.

Historically, the average unit selling prices of our products have declined substantially over the lives of the products, and we expect this trend to continue. A reduction in overall average selling prices of our products could result in reduced revenues and lower gross margins. Our ability to increase our net revenues and maintain our gross margins despite a decline in the average selling prices of our products will depend on a variety of factors, including our ability to introduce lower cost versions of our existing products, increase unit sales volumes of these products, and introduce new products with higher prices and greater margins. If we fail to accomplish any of these objectives, our business will suffer. To reduce our costs, we may be required to implement design changes that lower our manufacturing costs, negotiate reduced purchase prices from our independent foundries and our independent assembly and test vendors, and successfully manage our manufacturing and subcontractor relationships. Because we do not operate our own wafer foundry or assembly facilities, we may not be able to reduce our costs as rapidly as companies that operate their own foundries or facilities.

Current unfavorable economic and market conditions, domestically and internationally, may adversely affect our business, financial condition, results of operations and cash flows.

We have significant customer sales both in the United States and internationally. We also rely heavily on our suppliers in Asia. We are therefore susceptible to adverse U.S. and international economic and market conditions, including the economic difficulties resulting from the COVID-19 global pandemic that currently exist in the United States and worldwide. If any of our manufacturing partners, customers, distributors or suppliers experience serious financial difficulties or ceases operations, our business could be adversely affected.

System security risks, data protection, cyber-attacks and systems integration issues could disrupt our internal operations or the operations of our business partners, and any such disruption could harm our reputation or cause a reduction in our expected revenue, increase our expenses, negatively impact our results of operation or otherwise adversely affect our stock price.

Security breaches, computer malware and cyber-attacks have become more prevalent and sophisticated in recent years and may increase in the future due to a large number of our employees working from home during the COVID-19 global pandemic. Experienced computer programmers and hackers may be able to penetrate our network security or the network security of our business partners, and misappropriate or compromise our confidential and proprietary information, create system disruptions or cause shutdowns. The costs to us to eliminate or alleviate cyber or other security problems, bugs, viruses, worms, malicious software programs and security vulnerabilities could be significant, and our efforts to address these problems may not be successful and could result in interruptions and delays that may impede our sales, manufacturing, distribution or other critical functions.

34

We manage and store various proprietary information and sensitive or confidential data relating to our business on the cloud. Breaches of our security measures or the accidental loss, inadvertent disclosure or unapproved dissemination of proprietary information or confidential data about us, including the potential loss or disclosure of such information or data as a result of fraud, trickery or other forms of deception, could expose us to a risk of loss or misuse of this information, result in litigation and potential liability for us, damage our reputation or otherwise harm our business. In addition, the cost and operational consequences of implementing further data protection measures could be significant.

Portions of our IT infrastructure also may experience interruptions, delays or cessations of service or produce errors in connection with systems integration or migration work that takes place from time to time. We may not be successful in implementing new systems and transitioning data, which could cause business disruptions and be more expensive, time consuming, disruptive and resource-intensive than originally anticipated. Such disruptions could adversely impact our ability to fulfill orders and interrupt other processes and could adversely affect our financial results, stock price and reputation.

We may be unable to accurately predict future sales through our distributors, which could harm our ability to efficiently manage our resources to match market demand.

Our financial results, quarterly product sales, trends and comparisons are affected by fluctuations in the buying patterns of the OEMs that purchase our products from our distributors. While we attempt to assist our distributors in maintaining targeted stocking levels of our products, we may not consistently be accurate or successful. This process involves the exercise of judgment and use of assumptions as to future uncertainties, including end user demand. Inventory levels of our products held by our distributors may exceed or fall below the levels we consider desirable on a going-forward basis. This could result in distributors returning unsold inventory to us, or in us not having sufficient inventory to meet the demand for our products. If we are not able to accurately predict sales through our distributors or effectively manage our relationships with our distributors, our business and financial results will suffer.

A small number of customers generally account for a significant portion of our accounts receivable in any period, and if any one of them fails to pay us, our financial position and operating results will suffer.

At December 31, 2020, three customers accounted for 41%, 23% and 19% of our accounts receivable, respectively. If any of these customers do not pay us, our financial position and operating results will be harmed. Generally, we do not require collateral from our customers.

Demand for our products may decrease if our OEM customers experience difficulty manufacturing, marketing or selling their products.

Our products are used as components in our OEM customers’ products, including routers, switches and other networking and telecommunications products. Accordingly, demand for our products is subject to factors affecting the ability of our OEM customers to successfully introduce and market their products, including:

●capital spending by telecommunication and network service providers and other end-users who purchase our OEM customers’ products;

●the competition our OEM customers face, particularly in the networking and telecommunications industries;

●the technical, manufacturing, sales and marketing and management capabilities of our OEM customers;

●the financial and other resources of our OEM customers; and

●the inability of our OEM customers to sell their products if they infringe third-party intellectual property rights.

35

As a result, if OEM customers reduce their purchases of our products, our business will suffer.

Our products have lengthy sales cycles that make it difficult to plan our expenses and forecast results.

Our products are generally incorporated in our OEM customers’ products at the design stage. However, their decisions to use our products often require significant expenditures by us without any assurance of success, and often precede volume sales, if any, by a year or more. If an OEM customer decides at the design stage not to incorporate our products into their products, we will not have another opportunity for a design win with respect to that customer’s product for many months or years, if at all. Our sales cycle can take up to 24 months to complete, and because of this lengthy sales cycle, we may experience a delay between increasing expenses for research and development and our sales and marketing efforts and the generation of volume production revenues, if any, from these expenditures. Moreover, the value of any design win will largely depend on the commercial success of our OEM customers’ products. There can be no assurance that we will continue to achieve design wins or that any design win will result in future revenues.

Any significant order cancellations or order deferrals could adversely affect our operating results.

We typically sell products pursuant to purchase orders that customers can generally cancel or defer on short notice without incurring a significant penalty. Any significant cancellations or deferrals in the future could materially and adversely affect our business, financial condition and results of operations. Cancellations or deferrals could cause us to hold excess inventory, which could reduce our profit margins, increase product obsolescence and restrict our ability to fund our operations. We generally recognize revenue upon shipment of products to a customer. If a customer refuses to accept shipped products or does not pay for these products, we could miss future revenue projections or incur significant charges against our income, which could materially and adversely affect our operating results.

Claims that we infringe third party intellectual property rights could seriously harm our business and require us to incur significant costs.

In recent years, there has been significant litigation in the semiconductor industry involving patents and other intellectual property rights. We have recently been involved in protracted patent infringement litigation, and we could become subject to additional claims or litigation in the future as a result of allegations that we infringe others’ intellectual property rights or that our use of intellectual property otherwise violates the law. Claims that our products infringe the proprietary rights of others would force us to defend ourselves and possibly our customers, distributors or manufacturers against the alleged infringement. Any such litigation regarding intellectual property could result in substantial costs and diversion of resources and could have a material adverse effect on our business, financial condition and results of operations. Similarly, changing our products or processes to avoid infringing the rights of others may be costly or impractical. If any claims received in the future were to be upheld, the consequences to us could require us to:

●stop selling our products that incorporate the challenged intellectual property;

●obtain a license to sell or use the relevant technology, which license may not be available on reasonable terms or at all;

●pay damages; or

●redesign those products that use the disputed technology.

Although patent disputes in the semiconductor industry have often been settled through cross-licensing arrangements, we may not be able in any or every instance to settle an alleged patent infringement claim through a cross-licensing arrangement in part because we have a more limited patent portfolio than many of our competitors. If a successful claim is made against us or any of our customers and a license is not made available to us on commercially reasonable terms or we are required to pay substantial damages or awards, our business, financial condition and results of operations would be materially adversely affected.

36

Our acquisition of companies or technologies could prove difficult to integrate, disrupt our business, dilute stockholder value and adversely affect our operating results.

In November 2015, we acquired all of the outstanding capital stock of privately held MikaMonu Group Ltd., a development-stage, Israel-based company that specializes in in-place associative computing for markets including big data, computer vision and cyber security. We also acquired substantially all of the assets related to the SRAM memory device product line of Sony Corporation in 2009. We intend to supplement our internal development activities by seeking opportunities to make additional acquisitions or investments in companies, assets or technologies that we believe are complementary or strategic. Other than the MikaMonu and Sony acquisitions, we have not made any such acquisitions or investments, and therefore our experience as an organization in making such acquisitions and investments is limited. In connection with the MikaMonu acquisition, we are subject to risks related to potential problems, delays or unanticipated costs that may be encountered in the development of products based on the MikaMonu technology and the establishment of new markets and customer relationships for the potential new products. In addition, in connection with any future acquisitions or investments we may make, we face numerous other risks, including:

●difficulties in integrating operations, technologies, products and personnel;

●diversion of financial and managerial resources from existing operations;

●risk of overpaying for or misjudging the strategic fit of an acquired company, asset or technology;

●problems or liabilities stemming from defects of an acquired product or intellectual property litigation that may result from offering the acquired product in our markets;

●challenges in retaining key employees to maximize the value of the acquisition or investment;

●inability to generate sufficient return on investment;

●incurrence of significant one-time write-offs; and

●delays in customer purchases due to uncertainty.

If we proceed with additional acquisitions or investments, we may be required to use a considerable amount of our cash, or to finance the transaction through debt or equity securities offerings, which may decrease our financial liquidity or dilute our stockholders and affect the market price of our stock. As a result, if we fail to properly evaluate and execute acquisitions or investments, our business and prospects may be harmed.

We are substantially dependent on the continued services and performance of our senior management and other key personnel.

Our future success is substantially dependent on the continued services and continuing contributions of our senior management who must work together effectively in order to design our products, expand our business, increase our revenues and improve our operating results. Members of our senior management team have long-standing and important relationships with our key customers and suppliers. The loss of services, whether as a result of illness, retirement or death, of Lee-Lean Shu, our President and Chief Executive Officer, Robert Yau, our Vice President of Engineering, Dr. Avidan Akerib, our Vice President of Associative Computing, any other executive officer or other key employee could significantly delay or prevent the achievement of our development and strategic objectives. We do not have employment contracts with, nor maintain key person insurance on, any of our executive officers or other key employees.

37

If we are unable to recruit or retain qualified personnel, our business and product development efforts could be harmed.

We must continue to identify, recruit, hire, train, retain and motivate highly skilled technical, managerial, sales and marketing and administrative personnel. Competition for these individuals is intense, and we may not be able to successfully recruit, assimilate or retain sufficiently qualified personnel. We may encounter difficulties in recruiting and retaining a sufficient number of qualified engineers, which could harm our ability to develop new products and adversely impact our relationships with existing and future end-users at a critical stage of development. The failure to recruit and retain necessary technical, managerial, sales, marketing and administrative personnel could harm our business and our ability to obtain new OEM customers and develop new products.

Our business will suffer if we are unable to protect our intellectual property.

Our success and ability to compete depends in large part upon protecting our proprietary technology. We rely on a combination of patent, trade secret, copyright and trademark laws and non-disclosure and other contractual agreements to protect our proprietary rights. These agreements and measures may not be sufficient to protect our technology from third-party infringement. Monitoring unauthorized use of our intellectual property is difficult and we cannot be certain that the steps we have taken will prevent unauthorized use of our technology, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the United States. Our attempts to enforce our intellectual property rights could be time consuming and costly. We were recently involved in litigation to enforce our intellectual property rights and to protect our trade secrets. Additional litigation of this type may be necessary in the future. Any such litigation could result in substantial costs and diversion of resources. If competitors are able to use our technology without our approval or compensation, our ability to compete effectively could be harmed.

We may experience difficulties in transitioning to smaller geometry process technologies and other more advanced manufacturing process technologies, which may result in reduced manufacturing yields, delays in product deliveries and increased expenses.

In order to remain competitive, we expect to continue to transition the manufacture of our products to smaller geometry process technologies. This transition will require us to migrate to new manufacturing processes for our products and redesign certain products. The manufacture and design of our products is complex, and we may experience difficulty in transitioning to smaller geometry process technologies or new manufacturing processes. These difficulties could result in reduced manufacturing yields, delays in product deliveries and increased expenses. We are dependent on our relationships with TSMC to transition successfully to smaller geometry process technologies and to more advanced manufacturing processes. We cannot assure you that TSMC will be able to effectively manage the transition or that we will be able to maintain our relationship with them. If we or TSMC experience significant delays in this transition or fail to implement these transitions, our business, financial condition and results of operations could be materially and adversely affected.

Manufacturing process technologies are subject to rapid change and require significant expenditures for research and development.

We continuously evaluate the benefits of migrating to smaller geometry process technologies in order to improve performance and reduce costs. Historically, these migrations to new manufacturing processes have resulted in significant initial design and development costs associated with pre-production mask sets for the manufacture of new products with smaller geometry process technologies. For example, in the second quarter of fiscal 2019, we incurred approximately $1.0 million in research and development expense associated with a pre-production mask set that will not be used in production as part of the transition to our new 28 nanometer SRAM process technology for our APU product. We will incur similar expenses in the future as we continue to transition our products to smaller geometry processes. The costs inherent in the transition to new manufacturing process technologies will adversely affect our operating results and our gross margin.

38

Our products are complex to design and manufacture and could contain defects, which could reduce revenues or result in claims against us.

We develop complex products. Despite testing by us and our OEM customers, design or manufacturing errors may be found in existing or new products. These defects could result in a delay in recognition or loss of revenues, loss of market share or failure to achieve market acceptance. These defects may also cause us to incur significant warranty, support and repair costs, divert the attention of our engineering personnel from our product development efforts, result in a loss of market acceptance of our products and harm our relationships with our OEM customers. Our OEM customers could also seek and obtain damages from us for their losses. A product liability claim brought against us, even if unsuccessful, would likely be time consuming and costly to defend.

Defects in wafers and other components used in our products and arising from the manufacturing of these products may not be fully recoverable from TSMC or our other suppliers. For example, in the quarter ended December 31, 2005, we incurred a charge of approximately $900,000 related to the write-off of inventory resulting from an error in the assembly process at one of our suppliers. This write-off adversely affected our operating results for fiscal 2006.

If our business grows, such growth may place a significant strain on our management and operations and, as a result, our business may suffer.

We are endeavoring to expand our business, and any growth that we are successful in achieving could place a significant strain on our management systems, infrastructure and other resources. To manage the potential growth of our operations and resulting increases in the number of our personnel, we will need to invest the necessary capital to continue to improve our operational, financial and management controls and our reporting systems and procedures. Our controls, systems and procedures may prove to be inadequate should we experience significant growth. In addition, we may not have sufficient administrative staff to support our operations. For example, we currently have only five employees in our finance department in the United States, including our Chief Financial Officer. Furthermore, our officers have limited experience in managing large or rapidly growing businesses. If our management fails to respond effectively to changes in our business, our business may suffer.

Our international business exposes us to additional risks.

Products shipped to destinations outside of the United States accounted for 53.3%, 59.6%, 62.5% and 51.5% of our net revenues in the nine months ended December 31, 2020 and in fiscal 2020, 2019 and 2018, respectively. Moreover, a substantial portion of our products is manufactured and tested in Taiwan, and the software development for our associative computing products occurs in Israel. We intend to continue expanding our international business in the future. Conducting business outside of the United States subjects us to additional risks and challenges, including:

●heightened price sensitivity from customers in emerging markets;

●compliance with a wide variety of foreign laws and regulations and unexpected changes in these laws and regulations;

●uncertainties regarding taxes, tariffs, quotas, export controls and license requirements, trade wars, policies that favor domestic companies over nondomestic companies, including government efforts to provide for the development and growth of local competitors, and other trade barriers;

●potential political and economic instability in, or foreign conflicts that involve or affect, the countries in which we, our customers and our suppliers are located;

●local authorities’ decisions regarding travel restrictions, stay-at-home orders, testing requirements and other policies to address public health crises such as the COVID-19 global pandemic which have an adverse impact on the economy and demand for our products;

39

●difficulties in collecting accounts receivable and longer accounts receivable payment cycles;

●difficulties and costs of staffing and managing personnel, distributors and representatives across different geographic areas and cultures, including assuring compliance with the U. S. Foreign Corrupt Practices Act and other U. S. and foreign anti-corruption laws;

●limited protection for intellectual property rights in some countries; and

●fluctuations in freight rates and transportation disruptions.

Moreover, our reporting currency is the U.S. dollar. However, a portion of our cost of revenues and our operating expenses is denominated in currencies other than the U.S. dollar, primarily the New Taiwanese dollar. As a result, appreciation or depreciation of other currencies in relation to the U.S. dollar could result in transaction gains or losses that could impact our operating results. We do not currently engage in currency hedging activities to reduce the risk of financial exposure from fluctuations in foreign exchange rates.

Changes in Taiwan’s political, social and economic environment may affect our business performance.

Because much of the manufacturing and testing of our products is conducted in Taiwan, our business performance may be affected by changes in Taiwan’s political, social and economic environment. For example, any political instability resulting from the relationship among the United States, Taiwan and the People’s Republic of China could damage our business. Moreover, the role of the Taiwanese government in the Taiwanese economy is significant. Taiwanese policies toward economic liberalization, and laws and policies affecting technology companies, foreign investment, currency exchange rates, taxes and other matters could change, resulting in greater restrictions on our ability and our suppliers’ ability to do business and operate facilities in Taiwan. If any of these changes were to occur, our business could be harmed and our stock price could decline.

TSMC, as well as our other independent suppliers and many of our OEM customers, have operations in the Pacific Rim, an area subject to significant risk of earthquakes, typhoons and other natural disasters and adverse consequences related to the outbreak of contagious diseases such as COVID-19.

The foundry that manufactures our Fast SRAM, TSMC, and all of the principal independent suppliers that assemble and test our products are located in Taiwan. Many of our customers are also located in the Pacific Rim. The risk of an earthquake in these Pacific Rim locations is significant. The occurrence of an earthquake, typhoon or other natural disaster near the fabrication facilities of TSMC or our other independent suppliers could result in damage, power outages and other disruptions that impair their production and assembly capacity. Any disruption resulting from such events could cause significant delays in the production or shipment of our products until we are able to shift our manufacturing, assembling, packaging or production testing from the affected contractor to another third-party vendor. In such an event, we may not be able to obtain alternate foundry capacity on favorable terms, or at all.

40

The COVID-19 global pandemic, along with the previous outbreaks of SARS, H1N1 and the Avian Flu, has curtailed travel between and within countries, including in the Asia-Pacific region. Outbreaks of new contagious diseases or the resurgence of existing diseases that significantly affect the Asia-Pacific region could disrupt the operations of our key suppliers and manufacturing partners. In addition, our business could be harmed if such an outbreak resulted in travel being restricted, the implementation of stay-at-home or shelter-in-place orders or if it adversely affected the operations of our OEM customers or the demand for our products or our OEM customers’ products.

The United States could materially modify certain international trade agreements, or change tax provisions related to the global manufacturing and sales of our products.

A portion of our business activities are conducted in foreign countries, including Taiwan and Israel. Our business benefits from free trade agreements, and we also rely on various U.S. corporate tax provisions related to international commerce as we develop, manufacture, market and sell our products globally. Any action to materially modify international trade agreements, change corporate tax policy related to international commerce or mandate domestic production of goods, could adversely affect our business, financial condition and results of operations.

We may need to raise additional capital in the future, which may not be available on favorable terms or at all, and which may cause dilution to existing stockholders.

We may need to seek additional funding in the future. We do not know if we will be able to obtain additional financing on favorable terms, if at all. If we cannot raise funds on acceptable terms, if and when needed, we may not be able to develop or enhance our products, take advantage of future opportunities or respond to competitive pressures or unanticipated requirements, and we may be required to reduce operating costs, which could seriously harm our business. In addition, if we issue equity securities, our stockholders may experience dilution or the new equity securities may have rights, preferences or privileges senior to those of our common stock.

Some of our products are incorporated into advanced military electronics, and changes in international geopolitical circumstances and domestic budget considerations may hurt our business.

Some of our products are incorporated into advanced military electronics such as radar and guidance systems. Military expenditures and appropriations for such purchases rose significantly in recent years. However, if current U.S. military operations around the world are scaled back, demand for our products for use in military applications may decrease, and our operating results could suffer. Domestic budget considerations may also adversely affect our operating results. For example, if governmental appropriations for military purchases of electronic devices that include our products are reduced, our revenues will likely decline.

Our operations involve the use of hazardous and toxic materials, and we must comply with environmental laws and regulations, which can be expensive, and may affect our business and operating results.

We are subject to federal, state and local regulations relating to the use, handling, storage, disposal and human exposure to hazardous and toxic materials. If we were to violate or become liable under environmental laws in the future as a result of our inability to obtain permits, human error, accident, equipment failure or other causes, we could be subject to fines, costs, or civil or criminal sanctions, face property damage or personal injury claims or be required to incur substantial investigation or remediation costs, which could be material, or experience disruptions in our operations, any of which could have a material adverse effect on our business. In addition, environmental laws could become more stringent over time imposing greater compliance costs and increasing risks and penalties associated with violations, which could harm our business.

We face increasing complexity in our product design as we adjust to new and future requirements relating to the material composition of our products, including the restrictions on lead and other hazardous substances that apply to specified electronic products put on the market in the European Union, China and California. Other countries, including at the federal and state levels in the United States, are also considering similar laws and regulations. Certain electronic products that we maintain in inventory may be rendered obsolete if they are not in compliance with such laws and regulations, which could negatively impact our ability to generate revenue from

41

those products. Although we cannot predict the ultimate impact of any such new laws and regulations, they will likely result in additional costs, or in the worst case decreased revenue, and could even require that we redesign or change how we manufacture our products. Such redesigns result in additional costs and possible delayed or lost revenue.

Risks Relating to Our Common Stock and the Securities Market

The trading price of our common stock is subject to fluctuation and is likely to be volatile.

The trading price of our common stock may fluctuate significantly in response to a number of factors, some of which are beyond our control, including:

●the establishment of a market for our new associative computing products;

●actual or anticipated declines in operating results;

●changes in financial estimates or recommendations by securities analysts;

●the institution of legal proceedings against us or significant developments in such proceedings;

●announcements by us or our competitors of financial results, new products, significant technological innovations, contracts, acquisitions, strategic relationships, joint ventures, capital commitments or other events;

●changes in industry estimates of demand for Very Fast SRAM products;

●the gain or loss of significant orders or customers;

●recruitment or departure of key personnel; and

●market conditions in our industry, the industries of our customers and the economy as a whole.

In recent years the stock market in general, and the market for technology stocks in particular, have experienced extreme price fluctuations, which have often been unrelated to the operating performance of affected companies. The market price of our common stock might experience significant fluctuations in the future, including fluctuations unrelated to our performance. These fluctuations could materially adversely affect our business relationships, our ability to obtain future financing on favorable terms or otherwise harm our business. In addition, in the past, securities class action litigation has often been brought against a company following periods of volatility in the market price of its securities. This risk is especially acute for us because the extreme volatility of market prices of technology companies has resulted in a larger number of securities class action claims against them. Due to the potential volatility of our stock price, we may in the future be the target of similar litigation. Securities litigation could result in substantial costs and divert management’s attention and resources. This could harm our business and cause the value of our stock to decline.

Use of a portion of our cash reserves to repurchase shares of our common stock presents potential risks and disadvantages to us and our continuing stockholders.  

From November 2008 through December 2019 we repurchased and retired an aggregate of 12,004,779 shares of our common stock at a total cost of $60.7 million, including 3,846,153 shares repurchased at a total cost of $25 million pursuant to a modified “Dutch auction” self-tender offer that we completed in August 2014 and additional shares repurchased in the open market pursuant to our stock repurchase program. At December 31, 2020, we had outstanding authorization from our Board of Directors to purchase up to an additional $4.3 million of our common stock from time to time under our repurchase program. Although our Board has determined that these repurchases are in the best interests of our stockholders, they expose us to certain risks including:

42

●the risks resulting from a reduction in the size of our “public float,” which is the number of shares of our common stock that are owned by non-affiliated stockholders and available for trading in the securities markets, which may reduce the volume of trading in our shares and result in reduced liquidity and, potentially, lower trading prices;

●the risk that our stock price could decline and that we would be able to repurchase shares of our common stock in the future at a lower price per share than the prices we have paid in our tender offer and repurchase program; and

●the risk that the use of a portion of our cash reserves for this purpose has reduced, or may reduce, the amount of cash that would otherwise be available to pursue potential cash acquisitions or other strategic business opportunities.

Our executive officers, directors and entities affiliated with them hold a substantial percentage of our common stock.

As of January 31, 2021, our executive officers, directors and entities affiliated with them beneficially owned approximately 35% of our outstanding common stock. As a result, these stockholders will be able to exercise substantial influence over, and may be able to effectively control, matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, which could have the effect of delaying or preventing a third party from acquiring control over or merging with us.

The provisions of our charter documents might inhibit potential acquisition bids that a stockholder might believe are desirable, and the market price of our common stock could be lower as a result.

Our Board of Directors has the authority to issue up to 5,000,000 shares of preferred stock. Our Board of Directors can fix the price, rights, preferences, privileges and restrictions of the preferred stock without any further vote or action by our stockholders. The issuance of shares of preferred stock might delay or prevent a change in control transaction. As a result, the market price of our common stock and the voting and other rights of our stockholders might be adversely affected. The issuance of preferred stock might result in the loss of voting control to other stockholders. We have no current plans to issue any shares of preferred stock. Our charter documents also contain other provisions, which might discourage, delay or prevent a merger or acquisition, including:

●our stockholders have no right to remove directors without cause;

●our stockholders have no right to act by written consent;

●our stockholders have no right to call a special meeting of stockholders; and

●our stockholders must comply with advance notice requirements to nominate directors or submit proposals for consideration at stockholder meetings.

These provisions could also have the effect of discouraging others from making tender offers for our common stock. As a result, these provisions might prevent the market price of our common stock from increasing substantially in response to actual or rumored takeover attempts. These provisions might also prevent changes in our management.

43

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Stock Repurchase Program

Our Board of Directors has authorized us to repurchase, at management’s discretion, shares of our common stock. Under the repurchase program, we may repurchase shares from time to time on the open market or in private transactions. The specific timing and amount of the repurchases will be dependent on market conditions, securities law limitations and other factors. The repurchase program may be suspended or terminated at any time without prior notice. During the quarter ended December 31, 2020, we did not repurchase any of our shares under the repurchase program.

44

Item 6.Exhibits

Exhibit Number	Name of Document
31.1	Certification of Lee-Lean Shu, President, Chief Executive Officer and Chairman, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Douglas M. Schirle, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Lee-Lean Shu, President, Chief Executive Officer and Chairman, and Douglas M. Schirle, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

45

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: February 5, 2021
	GSI Technology, Inc.
	By:	/s/ LEE-LEAN SHU
		Lee-Lean Shu
		President, Chief Executive Officer and Chairman
	By:	/s/ DOUGLAS M. SCHIRLE
		Douglas M. Schirle
		Chief Financial Officer

46

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT

TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lee-Lean Shu, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GSI Technology, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

February 5, 2021

/s/ LEE-LEAN SHU

Lee-Lean Shu

President, Chief Executive Officer and Chairman

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT

TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Douglas M. Schirle, certify that:

1. I have reviewed this quarterly report on Form 10-Q of GSI Technology, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

February 5, 2021

/s/ DOUGLAS M. SCHIRLE

Douglas M. Schirle
Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of GSI Technology, Inc. (the “Company”) on Form 10-Q for the quarter ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officers of the Company, each certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

u
February 5, 2021
	/s/ LEE-LEAN SHU
	Lee-Lean Shu
	President, Chief Executive Officer and Chairman

OUG
	/s/ DOUGLAS M. SCHIRLE
	Douglas M. Schirle
	Chief Financial Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Dec. 31, 2020	Jan. 31, 2021
Document And Entity Information
Document Type	10-Q
Document Period End Date	Dec. 31, 2020
Entity Registrant Name	GSI TECHNOLOGY INC
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	GSIT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		23,797,963
Entity Central Index Key	0001126741
Current Fiscal Year End Date	--03-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Amendment Flag	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
ASSETS
Cash and cash equivalents	$ 43,064	$ 51,506
Short-term investments	9,196	15,061
Accounts receivable, net	4,012	6,330
Inventories	4,523	4,282
Prepaid expenses and other current assets	1,979	1,934
Total current assets	62,774	79,113
Property and equipment, net	7,444	8,119
Operating lease right-of-use assets	817	617
Long-term investments	10,126	4,117
Goodwill	7,978	7,978
Intangible assets, net	2,314	2,489
Other assets	139	128
Total assets	91,592	102,561
LIABILITIES AND STOCKHOLDERS EQUITY
Accounts payable	2,422	1,184
Lease liabilities, current	457	498
Accrued expenses and other liabilities	5,525	6,578
Total current liabilities	8,404	8,260
Income taxes payable	334	620
Lease liabilities, non-current	403	142
Contingent consideration, non-current	3,972	3,898
Total liabilities	13,113	12,920
Commitments and contingencies (Note 9)
Stockholders' equity:
Preferred stock: $0.001 par value authorized: 5,000,000 shares; issued and outstanding: none
Common Stock: $0.001 par value authorized: 150,000,000 shares; issued and outstanding: 23,795,963 and 23,229,286 shares, respectively	24	23
Additional paid-in capital	45,602	40,176
Accumulated other comprehensive income	5	71
Retained earnings	32,848	49,371
Total stockholders' equity	78,479	89,641
Total liabilities and stockholders' equity	$ 91,592	$ 102,561

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2020	Mar. 31, 2020
Stockholders' Equity
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	23,795,963	23,229,286
Common stock, shares outstanding	23,795,963	23,229,286

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Net revenues	$ 6,763	$ 10,049	$ 20,043	$ 34,808
Cost of revenues	3,566	4,000	10,684	13,948
Gross profit	3,197	6,049	9,359	20,860
Operating expenses:
Research and development	5,736	8,208	17,220	19,636
Selling, general and administrative	2,612	2,584	8,138	8,119
Total operating expenses	8,348	10,792	25,358	27,755
Loss from operations	(5,151)	(4,743)	(15,999)	(6,895)
Interest income, net	50	190	244	610
Other income (expense), net	(25)	17	(129)	(46)
Loss before income taxes	(5,126)	(4,536)	(15,884)	(6,331)
Provision for income taxes	90	84	639	182
Net loss	$ (5,216)	$ (4,620)	$ (16,523)	$ (6,513)
Net loss per share:
Basic	$ (0.22)	$ (0.20)	$ (0.70)	$ (0.28)
Diluted	$ (0.22)	$ (0.20)	$ (0.70)	$ (0.28)
Weighted average shares used in per share calculations:
Basic	23,716	23,096	23,592	22,894
Diluted	23,716	23,096	23,592	22,894

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Statement of Income and Comprehensive Income [Abstract]
Net loss	$ (5,216)	$ (4,620)	$ (16,523)	$ (6,513)
Net unrealized gain (loss) on available-for-sale investments	(38)	(11)	(66)	54
Total comprehensive loss	$ (5,254)	$ (4,631)	$ (16,589)	$ (6,459)

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Total
Beginning Balance - Shares at Mar. 31, 2019	22,320,156
Beginning Balance - Amount at Mar. 31, 2019	$ 22	$ 33,462	$ (37)	$ 59,708	$ 93,155
Issuance of common stock under employee stock option plans, shares	812,842
Issuance of common stock under employee stock option plans, amount	$ 1	3,628			3,629
Stock-based compensation expense		1,922			1,922
Comprehensive loss:
Net loss				(6,513)	(6,513)
Net unrealized gain (loss) on available-for-sale investments			54		54
Ending Balance, Shares at Dec. 31, 2019	23,132,998
Ending Balance, Amount at Dec. 31, 2019	$ 23	39,012	17	53,195	92,247
Beginning Balance - Shares at Sep. 30, 2019	23,052,473
Beginning Balance - Amount at Sep. 30, 2019	$ 23	37,903	28	57,815	95,769
Issuance of common stock under employee stock option plans, shares	80,525
Issuance of common stock under employee stock option plans, amount		480			480
Stock-based compensation expense		629			629
Comprehensive loss:
Net loss				(4,620)	(4,620)
Net unrealized gain (loss) on available-for-sale investments			(11)		(11)
Ending Balance, Shares at Dec. 31, 2019	23,132,998
Ending Balance, Amount at Dec. 31, 2019	$ 23	39,012	17	53,195	92,247
Beginning Balance - Shares at Mar. 31, 2020	23,229,286
Beginning Balance - Amount at Mar. 31, 2020	$ 23	40,176	71	49,371	89,641
Issuance of common stock under employee stock option plans, shares	566,677
Issuance of common stock under employee stock option plans, amount	$ 1	3,325			3,326
Stock-based compensation expense		2,101			2,101
Comprehensive loss:
Net loss				(16,523)	(16,523)
Net unrealized gain (loss) on available-for-sale investments			(66)		(66)
Ending Balance, Shares at Dec. 31, 2020	23,795,963
Ending Balance, Amount at Dec. 31, 2020	$ 24	45,602	5	32,848	78,479
Beginning Balance - Shares at Sep. 30, 2020	23,641,426
Beginning Balance - Amount at Sep. 30, 2020	$ 24	44,092	43	38,064	82,223
Issuance of common stock under employee stock option plans, shares	154,537
Issuance of common stock under employee stock option plans, amount		817			817
Stock-based compensation expense		693			693
Comprehensive loss:
Net loss				(5,216)	(5,216)
Net unrealized gain (loss) on available-for-sale investments			(38)		(38)
Ending Balance, Shares at Dec. 31, 2020	23,795,963
Ending Balance, Amount at Dec. 31, 2020	$ 24	$ 45,602	$ 5	$ 32,848	$ 78,479

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (16,523)	$ (6,513)
Adjustments to reconcile net loss to net cash used in operating activities:
Allowance for doubtful accounts and other	(25)	(32)
Provision for excess and obsolete inventories	327	260
Non-cash lease expense	458	462
Depreciation and amortization	962	1,079
Stock-based compensation	2,101	1,922
Amortization of premium (discount) on investments	49	(14)
Changes in assets and liabilities:
Accounts receivable	2,343	1,973
Inventory	(568)	904
Prepaid expenses and other assets	(56)	(1,064)
Accounts payable	1,238	(728)
Accrued expenses and other liabilities	(1,693)	531
Net cash used in operating activities	(11,387)	(1,220)
Cash flows from investing activities:
Purchase of investments	(17,509)	(15,866)
Maturities of short-term investments	17,250	18,626
Decrease in MikaMonu escrow deposit		1,000
Purchases of property and equipment	(122)	(265)
Net cash provided by (used in) investing activities	(381)	3,495
Cash flows from financing activities:
Payment of MikaMonu escrow deposit		(428)
Proceeds from issuance of common stock under employee stock plans	3,326	3,629
Net cash provided by financing activities	3,326	3,201
Net increase (decrease) in cash and cash equivalents	(8,442)	5,476
Cash and cash equivalents at beginning of the period	51,506	42,495
Cash and cash equivalents at end of the period	43,064	47,971
Non-cash financing activities:
Purchases of property and equipment through accounts payable and accruals	9	24
Operating lease right-of-use assets exchanged for lease obligations	658	1,228
Supplemental cash flow information:
Net cash paid for income taxes	$ 857	$ 310

XML

1. THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Dec. 31, 2020

The Company And Summary Of Significant Accounting Policies

NOTE 1-THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1—THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The accompanying unaudited condensed consolidated financial statements of GSI Technology, Inc. and its subsidiaries (“GSI” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission.  Accordingly, the interim financial statements do not include all of the information and footnotes required by GAAP for annual financial statements.  These interim financial statements contain all adjustments (which consist of only normal, recurring adjustments) that are, in the opinion of management, necessary to state fairly the interim financial information included therein.  The Company believes that the disclosures are adequate to make the information not misleading.  However, these financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

The consolidated results of operations for the nine months ended December 31, 2020 are not necessarily indicative of the results to be expected for the entire fiscal year.

Significant accounting policies

Except for the changes in disclosure requirements for recurring and nonrecurring fair value measurements and changes in goodwill impairment testing, which were updated as a result of adopting new accounting standards, there have been no material changes to our significant accounting policies that were disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

Risk and uncertainties

On March 11, 2020, the World Health Organization announced that COVID-19, a respiratory illness caused by a novel coronavirus, is a pandemic. COVID-19 has spread to many of the countries in which the Company, its customers, suppliers and other business partners conduct business. Governments in affected regions have implemented, and may continue to implement, safety precautions which include quarantines, travel restrictions, business closures, cancellations of public gatherings and other measures as they deem necessary. Many organizations and individuals, including the Company and its employees, are taking additional steps to avoid or reduce infection, including limiting travel and working from home. These measures are disrupting normal business operations both in and outside of affected areas and have had significant negative impacts on businesses and financial markets worldwide.

The Company continues to monitor its operations and government recommendations and has made modifications to its normal operations because of the COVID-19 global pandemic. The Company has instituted many preventative measures and is regularly evaluating those measures and others as it continues to better understand its current and future operating environment. Except for the Company’s employees located in Taiwan, the majority of its employees are working from home around the world. The Company has maintained a substantial portion of its manufacturing operational capacity at its primary manufacturing support facility located in Hsin Chu, Taiwan where the Company’s suppliers are located and where all of the Company’s products are manufactured. Since the outbreak of COVID-19, aside from the lengthening of lead times for wafers and assembly services, the Company has experienced minimal impact on its manufacturing operations in Taiwan. Final testing of the Company’s products is conducted in house. Shipping and receiving operations are being maintained by a skeleton crew with minimal impact. The Company’s revenues have been and are expected to continue to be impacted by changes in customer buying patterns and communication limitations related to shelter in place restrictions that require a significant number of its customer contacts to work from home. The Company’s results for the three month and nine month periods ended December 31, 2020 demonstrate the challenges that the Company is facing during the COVID-19 global pandemic, which has restricted the activities of the Company’s sales force and distributors, reduced customer demand and caused the postponement of investment in certain customer sectors. These challenges are also impacting the Company as it enters new markets and engages with target customers. Industry conferences and on-site training workshops, which are typically used for building a sales pipeline, are unavailable due to COVID-19 related restrictions. The Company has adapted its sales strategies for the COVID-19 environment, where it cannot do face-to-face meetings and conduct secure meetings with government and defense customers, but the Company is still not operating at an optimal level.

The disruption to the marketplace resulting from the COVID-19 global pandemic that the Company continues to experience is unlike anything the Company has ever had to deal with. While the Company continues to monitor the business metrics that it has historically used to predict its financial performance, the Company is uncertain as to whether these metrics will operate consistently with its historical experience.

The Company believes that during the next 12 months the COVID-19 pandemic could impact general economic activity and demand in its end markets. Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it is expected to have an adverse effect on the Company’s results of operations, financial position, and liquidity during fiscal year 2021 and into fiscal year 2022. This includes results from new information that may emerge concerning COVID-19 and any actions taken to contain or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. The Company has made estimates of the impact of COVID-19 within its financial statements and there may be changes to those estimates in future periods.

Accounting pronouncements recently adopted

In August 2018, the Financial Accounting Standards Board (“FASB”)  issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement.” The standard amends the disclosure requirements for recurring and nonrecurring fair value measurements by removing, modifying, and adding certain disclosures. The Company adopted ASU No. 2018-13 in the quarter ended June 30, 2020.Implementation of this guidance did not have a material impact on the Company’s consolidated financial statements and related disclosures.

In January 2017, the FASB issued ASU No. 2017-04, "Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The standard eliminates the second step in the goodwill impairment test which requires an entity to determine the implied fair value of the reporting unit’s goodwill.  Instead, an entity should recognize an impairment loss if the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, with the impairment loss not to exceed the amount of goodwill allocated to the reporting unit. The Company adopted ASU No. 2017-04 in the quarter ended June 30, 2020.Implementation of this guidance did not have a material impact on the Company’s consolidated financial statements and related disclosures.

Accounting pronouncements not yet effective for fiscal 2021

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” as part of its initiative to reduce complexity in the accounting standards.The standard eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact that this guidance will have upon its financial position and results of operations, if any.

In June 2016, the FASB issued ASU No. 2016-13,  “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other receivables, loans, and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted beginning April 1, 2019. Application of the amendments is through a cumulative-effect adjustment to retained earnings as of the effective date. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

XML

2. REVENUE RECOGNITION

9 Months Ended

Dec. 31, 2020

REVENUE RECOGNITION.

Note 2 - REVENUE RECOGNITION

NOTE 2—REVENUE RECOGNITION

The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, we satisfy a performance obligation.

The majority of the Company’s customer contracts, which may be in the form of purchase orders, contracts or purchase agreements, contain performance obligations for delivery of agreed upon products.  Delivery of all performance obligations contained within a contract with a customer typically occurs at the same time (or within the same accounting period).  Transfer of control typically occurs at the time of shipment or at the time the product is pulled from consignment as that is the point at which delivery has occurred, title and the risks and rewards of ownership have passed to the customer, and the Company has a right to payment. Thus, the Company will generally recognize revenue upon shipment of the product.

Because all of the Company’s performance obligations relate to contracts with a duration of less than one year, the Company has elected to apply the optional exemption practical expedient provided in ASC 606 and, therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

The Company adjusts the transaction price for variable consideration.  Variable consideration is not typically significant and primarily results from stock rotation rights and quick pay discounts provided to certain distributors. As a practical expedient, the Company is recognizing the incremental costs of obtaining a contract, specifically commission expenses that have a period of benefit of less than twelve months, as an expense when incurred.  Additionally, the Company has adopted an accounting policy to recognize shipping costs that occur after control transfers to the customer as a fulfillment activity.

The Company’s contracts with customers do not typically include extended payment terms. Payment terms vary by contract type and type of customer and generally range from 30 to 60 days from shipment. Additionally, the Company has right to payment upon shipment.

The Company records revenue net of sales tax, value added tax, excise tax and other taxes collected concurrent with product sales. The impact of such taxes on products sales is immaterial. The Company has also elected to recognize the cost for freight and shipping when control over the products sold passes to customers and revenue is recognized.

The Company warrants its products to be free of defects generally for a period of three years. The Company estimates its warranty costs based on historical warranty claim experience and includes such costs in cost of revenues. Warranty costs and the accrued warranty liability were not material as of December 31, 2020.

The majority of the Company’s revenue is derived from sales of SRAM products which represent approximately 98% of total revenues in the nine months ended December 31, 2020.

Nokia, the Company’s largest customer, purchases products directly from the Company and through contract manufacturers and distributors.Based on information provided to the Company by its contract manufacturers and distributors, purchases by Nokia represented approximately 40% of the Company’s net revenues in the nine months ended December 31, 2020 and 2019.

See “Note 12 — Segment and Geographic Information” for revenue by shipment destination.

The following table presents the Company’s revenue disaggregated by customer type.

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands)
Contract manufacturers	$	3,154	$	3,022	$	9,007	$	11,745
Distribution		3,586		6,603		10,692		21,346
OEMs		23		424		344		1,717
	$	6,763	$	10,049	$	20,043	$	34,808

XML

3. NET LOSS PER COMMON SHARE

9 Months Ended

Dec. 31, 2020

NET LOSS PER COMMON SHARE

NOTE 3 - NET LOSS PER COMMON SHARE

NOTE 3—NET LOSS PER COMMON SHARE

The Company uses the treasury stock method to calculate the weighted average shares used in computing diluted net loss per share. The following table sets forth the computation of basic and diluted net loss per share:

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands, except per share amounts)
Net loss	$	(5,216)	$	(4,620)	$	(16,523)	$	(6,513)
Denominators:
Weighted average shares—Basic		23,716		23,096		23,592		22,894
Dilutive effect of employee stock options		—		—		—		—
Dilutive effect of employee stock purchase plan options		—		—		—		—
Weighted average shares—Dilutive		23,716		23,096		23,592		22,894
Net loss per common share—Basic	$	(0.22)	$	(0.20)	$	(0.70)	$	(0.28)
Net loss per common share—Diluted	$	(0.22)	$	(0.20)	$	(0.70)	$	(0.28)

The following shares of common stock underlying outstanding stock options, determined on a weighted average basis, were excluded from the computation of diluted net loss per share as they had an anti-dilutive effect:

	Three Months Ended December 31,		Nine Months Ended December 31,
	2020	2019	2020	2019
	(In thousands)
Shares underlying options and ESPP shares	5,181	4,048	4,856	3,762

XML

4. BALANCE SHEET DETAIL

9 Months Ended

Dec. 31, 2020

BALANCE SHEET DETAIL

NOTE 4 - BALANCE SHEET DETAIL

NOTE 4—BALANCE SHEET DETAIL

	December 31, 2020		March 31, 2020
	(In thousands)
Inventories:
Work-in-progress	$	1,924	$	1,650
Finished goods		2,572		2,612
Inventory at distributors		27		20
	$	4,523	$	4,282

	December 31, 2020		March 31, 2020
	(In thousands)
Accounts receivable, net:
Accounts receivable	$	4,072	$	6,415
Less: Allowances for doubtful accounts and other		(60)		(85)
	$	4,012	$	6,330

	December 31, 2020		March 31, 2020
	(In thousands)
Prepaid expenses and other current assets:
Prepaid tooling and masks	$	783	$	707
Prepaid income taxes		45		79
Other receivables		234		211
Other prepaid expenses and other current assets		917		937
	$	1,979	$	1,934

	December 31, 2020		March 31, 2020
	(In thousands)
Property and equipment, net:
Computer and other equipment	$	18,289	$	18,191
Software		4,097		4,086
Land		3,900		3,900
Building and building improvements		3,735		3,735
Furniture and fixtures		102		102
Leasehold improvements		877		874
		31,000		30,888
Less: Accumulated depreciation		(23,556)		(22,769)
	$	7,444	$	8,119

Depreciation expense was $197,000 and $293,000 for the three months ended December 31, 2020 and 2019, respectively, and $787,000 and $904,000 for the nine months ended December 31, 2020 and 2019, respectively.

	December 31, 2020		March 31, 2020
	(In thousands)
Other assets:
Deposits	$	139	$	128
	$	139	$	128

The following tables summarize the components of intangible assets and related accumulated amortization balances at December 31, 2020 and March 31, 2020 (in thousands):

	As of December 31, 2020
	Gross Carrying Amount		Accumulated amortization		Net Carrying Amount
Intangible assets:
Product designs	$	590	$	(590)	$	—
Patents		4,220		(1,906)		2,314
Software		80		(80)		—
Total	$	4,890	$	(2,576)	$	2,314

	As of March 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Intangible assets:
Product designs	$	590	$	(590)	$	—
Patents		4,220		(1,731)		2,489
Software		80		(80)		—
Total	$	4,890	$	(2,401)	$	2,489

Amortization of intangible assets included in cost of revenues was $58,000 and $58,000 for the three months ended December 31, 2020 and 2019, respectively, and $175,000 and $175,000 for the nine months ended December 31, 2020 and 2019, respectively.

As of December 31, 2020, the estimated future amortization expense of intangible assets in the table above is as follows (in thousands):

Fiscal year ending March 31,
2021 (Remaining three months)	$	58
2022		233
2023		233
2024		233
2025		233
Thereafter		1,324
Total	$	2,314

	December 31, 2020		March 31, 2020
	(In thousands)
Accrued expenses and other liabilities:
Accrued compensation	$	3,959	$	3,673
Purchased intellectual property		—		1,621
Accrued commissions		223		270
Income taxes payable		211		143
Miscellaneous accrued expenses		1,132		871
	$	5,525	$	6,578

XML

5. GOODWILL

9 Months Ended

Dec. 31, 2020

GOODWILL

NOTE 5 - GOODWILL

NOTE 5—GOODWILL

Goodwill represents the difference between the purchase price and the estimated fair value of the identifiable assets acquired and liabilities assumed in a business combination. The Company tests for goodwill impairment on an annual basis, or more frequently if events or changes in circumstances indicate that the asset is more likely than not impaired. The Company has one reporting unit. The Company assesses goodwill for impairment on an annual basis on the last day of February in the fourth quarter of its fiscal year.

The Company had a goodwill balance of $8.0 million as of both March 31, 2020 and December 31, 2020. The goodwill resulted from the acquisition of MikaMonu Group Ltd. in fiscal 2016.

The Company utilized a two-step quantitative analysis to complete its annual impairment test during the fourth quarter of fiscal 2020 and concluded that there was no impairment, as the fair value of its sole reporting unit exceeded its carrying value. The Company determined that the second step of the impairment test was not necessary. No triggering event took place subsequent to the fiscal 2020 annual assessment that necessitated a quantitative impairment analysis for the Company’s one reporting unit.

XML

6. INCOME TAXES

9 Months Ended

Dec. 31, 2020

INCOME TAXES

NOTE 6 - INCOME TAXES

NOTE 6—INCOME TAXES

The current portion of the Company’s unrecognized tax benefits was $0 at both December 31, 2020 and March 31, 2020. The long-term portion at December 31, 2020 and March 31, 2020 was $326,000 and $613,000, respectively, of which the timing of the resolution is uncertain.  As of December 31, 2020, $3.0 million of unrecognized tax benefits had been recorded as a reduction to net deferred tax assets.  As of December 31, 2020, the Company’s net deferred tax assets of $12.4 million were subject to a valuation allowance of $12.4 million.As of March 31, 2020, the Company’s net deferred tax assets of $9.4 million were subject to a valuation allowance of $9.4 million.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted. The CARES Act is an approximate $2 trillion emergency economic stimulus package passed in response to the COVID-19 global pandemic. The CARES Act contains numerous income tax provisions including changes to the net operating loss rules that the Company believes will not have a significant impact.

Management believes that within the next twelve months the Company will not have a significant reduction in uncertain tax benefits, including interest and penalties, related to positions taken with respect to credits and loss carryforwards on previously filed tax returns.

The Company’s policy is to include interest and penalties related to unrecognized tax benefits within the provision for income taxes in the Condensed Consolidated Statements of Operations.

The Company is subject to taxation in the United States and various state and foreign jurisdictions.  Fiscal years 2013 through 2020 remain open to examination by federal tax authorities, and fiscal years 2012 through 2020 remain open to examination by California tax authorities. During the quarter ended June 30, 2020, the Company settled an income tax audit in Israel for fiscal years 2016 through 2019 that resulted in a discrete tax provision of $479,000 and a tax liability of $713,000 as of June 30, 2020 that was paid in the quarter ended September 30, 2020.

The Company’s estimated annual effective income tax rate, including discrete items, was approximately (3.4%) and (2.2%) as of December 31, 2020 and 2019, respectively. The annual effective tax rates as of December 31, 2020 and 2019 vary from the United States statutory income tax rate primarily due to valuation allowances in the United States, whereby pre-tax losses do not result in the recognition of corresponding income tax benefits and expenses and the foreign tax differential.

XML

7. FINANCIAL INSTRUMENTS

9 Months Ended

Dec. 31, 2020

FINANCIAL INSTRUMENTS

NOTE 7 - FINANCIAL INSTRUMENTS

NOTE 7—FINANCIAL INSTRUMENTS

Fair value measurements

Authoritative accounting guidance for fair value measurements provides a framework for measuring fair value and related disclosures.  The guidance applies to all financial assets and financial liabilities that are measured on a recurring basis.  The guidance requires fair value measurement to be classified and disclosed in one of the following three categories:

Level 1: Valuations based on quoted prices in active markets for identical assets and liabilities.  The fair value of available-for-sale securities included in the Level 1 category is based on quoted prices that are readily and regularly available in an active market.  As of December 31, 2020, the Level 1 category included money market funds of$23.2 million, which were included in cash and cash equivalents on the Condensed Consolidated Balance Sheets.

Level 2: Valuations based on observable inputs (other than Level 1 prices), such as quoted prices for similar assets at the measurement date; quoted prices in markets that are not active; or other inputs that are observable, either directly or indirectly. The fair value of available-for-sale securities included in the Level 2 category is based on the market values obtained from an independent pricing service that were evaluated using pricing models that vary by asset class and may incorporate available trade, bid and other market information and price quotes from well-established independent pricing vendors and broker-dealers. As of December 31, 2020, the Level 2 category included short-term investments of $9.2 million and long-term investments of $10.1 million, which were comprised of certificates of deposit, government and agency securities.

Level 3: Valuations based on inputs that are unobservable and involve management judgment and the reporting entity’s own assumptions about market participants and pricing.  As of December 31, 2020, the Company’s Level 3 financial instruments measured at fair value on the Condensed Consolidated Balance Sheets consisted of the contingent consideration liability related to the acquisition of MikaMonu. The fair value of the contingent consideration liability was initially determined as of the acquisition date using unobservable inputs.  These inputs included the estimated amount and timing of future cash flows, the probability of success (achievement of the various contingent events) and a risk-adjusted discount rate of approximately 14.8% used to adjust the probability-weighted cash flows to their present value.  Significant increases (decreases) in any of those inputs in isolation would result in a significantly higher (lower) fair value measurement. Generally, changes used in the assumptions for future cash flows and probability of success would be accompanied by a directionally similar change in the fair value measurement and expense. Conversely, changes in the risk-adjusted discount rate would be accompanied by a directionally opposite change in the related fair value measurement and expense. Subsequent to the acquisition date, at each reporting period, the contingent consideration liability is re-measured to fair value with changes recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations. During the most recent re-measurement of the contingent consideration liability as of March 31, 2020, the Company used a risk-adjusted discount rate of approximately 14.5% to adjust the probability-weighted cash flows to their present value using probabilities ranging from 0% to 10% for the remaining contingent events. The contingent consideration liability is included in contingent consideration, non-current on the Consolidated Balance Sheet at December 31, 2020 and March 31, 2020 in the amount of $4.0 million and $3.9 million, respectively.

The fair value of financial assets measured on a recurring basis is as follows (in thousands):

			Fair Value Measurements at Reporting Date Using
			Quoted Prices
			in Active		Significant
			Markets for		Other		Significant
			Identical Assets		Observable		Unobservable
			and Liabilities		Inputs		Inputs
	December 31, 2020		(Level 1)		(Level 2)		(Level 3)
Assets:
Money market funds	$	23,160	$	23,160	$	—	$	—
Marketable securities		19,322		—		19,322		—
Total	$	42,482	$	23,160	$	19,322	$	—
Liabilities:
Contingent consideration	$	3,972	$	—	$	—	$	3,972

			Fair Value Measurements at Reporting Date Using
			Quoted Prices
			in Active		Significant
			Markets for		Other		Significant
			Identical Assets		Observable		Unobservable
			and Liabilities		Inputs		Inputs
	March 31, 2020		(Level 1)		(Level 2)		(Level 3)
Assets:
Money market funds	$	14,117	$	14,117	$	—	$	—
Marketable securities		19,178		—		19,178		—
Total	$	33,295	$	14,117	$	19,178	$	—
Liabilities:
Contingent consideration	$	3,898	$	—	$	—	$	3,898

The following table sets forth the changes in fair value of contingent consideration for the nine months ended December 31, 2020 and December 31, 2019:

	Nine Months Ended December 31,
	2020		2019
	(In thousands)
Contingent consideration, beginning of period	$	3,898	$	4,206
Change due to accretion		74		87
Payment of contingent consideration		—		(500)
Contingent consideration, end of period	$	3,972	$	3,793

Short-term and long-term investments

All of the Company’s short-term and long-term investments are classified as available-for-sale.  Available-for-sale debt securities with maturities greater than twelve months are classified as long-term investments when they are not intended for use in current operations.  Investments in available-for-sale securities are reported at fair value with unrecognized gains (losses), net of tax, as a component of accumulated other comprehensive loss in the Condensed Consolidated Balance Sheets.  The Company had money market funds of $23.2 million and $14.1 million at December 31, 2020 and March 31, 2020, respectively, included in cash and cash equivalents on the Condensed Consolidated Balance Sheets.  The Company monitors its investments for impairment periodically and records appropriate reductions in carrying values when declines are determined to be other-than-temporary.

The following table summarizes the Company’s available-for-sale investments:

	December 31, 2020
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
	(In thousands)
Short-term investments:
Certificates of deposit	$	2,495	$	14	$	—	$	2,509
Supranational obligations		2,765		5		—		2,770
Agency bonds		3,918		—		(1)		3,917
Total short-term investments	$	9,178	$	19	$	(1)	$	9,196
Long-term investments:
Certificates of deposit	$	4,000	$	31	$	—	$	4,031
Supranational obligations		2,047		—		(1)		2,046
Agency bonds		4,018		31		—		4,049
Total long-term investments	$	10,065	$	62	$	(1)	$	10,126

	March 31, 2020
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
	(In thousands)
Short-term investments:
Certificates of deposit	$	12,000	$	52	$	(1)	$	12,051
Agency bonds		2,989		21		—		3,010
Total short-term investments	$	14,989	$	73	$	(1)	$	15,061
Long-term investments:
Certificates of deposit	$	745	$	18	$	—	$	763
Agency bonds		2,029		42		—		2,071
Supranational obligations		1,270		13		—		1,283
Total long-term investments	$	4,044	$	73	$	—	$	4,117

The following table shows the gross unrealized losses and fair value of the Company’s investments with unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous loss position as of December 31, 2020 and March 31, 2020, respectively.

	December 31, 2020
	Less Than 12 Months				12 Months or Greater				Total
		Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
		Value		Loss		Value		Loss		Value		Loss
	(In thousands)
Agency bonds	$	4,918	$	(1)	$	—	$	—	$	4,918	$	(1)
Certificates of deposit		250		(1)		—		—		250		(1)
Supranational obligations		2,523		(1)		—		—		2,523		(1)
	$	7,691	$	(3)	$	—	$	—	$	7,691	$	(3)

	March 31, 2020
	Less Than 12 Months				12 Months or Greater				Total
		Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
		Value		Loss		Value		Loss		Value		Loss
	(In thousands)
Certificates of deposit	$	2,498	$	(2)	$	-	$	-	$	2,498	$	(2)
	$	2,498	$	(2)	$	-	$	-	$	2,498	$	(2)

The Company’s investment portfolio consists of both corporate and governmental securities that have a maximum maturity of three years. All unrealized gains and losses are due to changes in interest rates and bond yields.  Subject to normal credit risks, the Company has the ability to realize the full value of all these investments upon maturity.

The deferred tax liability related to unrecognized gains and losses on short-term and long-term investments was $(22,000) and $(30,000) at December 31, 2020 and March 31, 2020, respectively.

As of December 31, 2020, contractual maturities of the Company’s available-for-sale investments were as follows:

			Fair
	Cost		Value
	(In thousands)
Maturing within one year	$	9,178	$	9,196
Maturing in one to three years		10,065		10,126
	$	19,243	$	19,322

The Company classifies its short-term investments as “available-for-sale” as they are intended to be available for use in current operations.

XML

8. LEASES

9 Months Ended

Dec. 31, 2020

LEASES

NOTE 8 - LEASES

NOTE 8—LEASES

The Company has operating leases for corporate offices, research and development facilities, certain equipment and software. The Company’s leases have remaining lease terms of 2 months to 32 months, some of which include options to extend for up to 5 years.

Supplemental balance sheet information related to leases was as follows:

	As of		As of
	December 31, 2020		March 31, 2020
	(In thousands)
Operating Leases
Operating lease right-of-use assets	$	817	$	617
Lease liabilities-current	$	457	$	498
Lease liabilities-non-current		403		142
Total operating lease liabilities	$	860	$	640

The following table provides the details of lease costs:

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands)				(In thousands)
Operating lease cost	$	172	$	164	$	504	$	483
Short-term lease cost		8		7		23		21
	$	180	$	171	$	527	$	504

The following table provides other information related to leases:

	Nine Months Ended December 31,
	2020		2019
	(In thousands)
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	175	$	488
Right-of-use assets obtained in exchange for lease obligations
Operating leases	$	658	$	1,228
Weighted-average remaining lease term (years):
Operating leases		2.2		1.5
Weighted-average discount rate:
Operating leases		4.86%		6.46%

The following table provides the maturities of the Company’s operating lease liabilities as of December 31, 2020:

	Operating Lease
	Liabilities
Fiscal Year	(In thousands)
2021 (Remaining three months)	$	154
2022		395
2023		251
2024		102
Total undiscounted future cash flows		902
Less: Imputed interest		(42)
Present value of undiscounted future cash flows	$	860
Presentation on statement of financial position
Current	$	457
Non-current	$	403

XML

9. COMMITMENTS AND CONTINGENCIES

9 Months Ended

Dec. 31, 2020

COMMITMENTS AND CONTINGENCIES

NOTE 9 - COMMITMENTS AND CONTINGENCIES

NOTE 9—COMMITMENTS AND CONTINGENCIES

Indemnification obligations

The Company is a party to a variety of agreements pursuant to which it may be obligated to indemnify the other party with respect to certain matters. Typically, these obligations arise in the context of contracts entered into by the Company, under which the Company agrees to hold the other party harmless against losses arising from a breach of representations and covenants related to such matters as title to assets sold and certain intellectual property rights. In each of these circumstances, payment by the Company is conditioned on the other party making a claim pursuant to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party’s claims. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by it under these agreements.

It is not possible to predict the maximum potential amount of future payments that may be required under these or similar agreements due to the conditional nature of the Company’s obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments made by the Company under these agreements have not had a material effect on its business, financial condition, cash flows or results of operations.

Product warranties

The Company warrants its products to be free of defects generally for a period of three years. The Company estimates its warranty costs based on historical warranty claim experience and includes such costs in cost of revenues. Warranty costs and the accrued warranty liability were not material as of December 31, 2020 and March 31, 2020 and for the three months ended December 31, 2020 or 2019.

XML

10. STOCK-BASED COMPENSATION

9 Months Ended

Dec. 31, 2020

STOCK-BASED COMPENSATION

NOTE 10 - STOCK-BASED COMPENSATION

NOTE 10—STOCK-BASED COMPENSATION

As of December 31, 2020, 1,576,722 shares of common stock were available for grant under the Company’s 2016 Equity Incentive Plan.

The following table summarizes the Company’s stock option activities for the nine months ended December 31, 2020:

			Weighted
		Number of Shares	Average	Weighted
	Shares	Underlying	Remaining	Average
	Available for	Options	Contractual	Exercise		Intrinsic
	Grant	Outstanding	Life (Years)	Price		Value
Balance at March 31, 2020	2,522,314	8,135,791		$	6.17
Granted	(989,842)	989,842		$	6.14
Exercised	—	(443,190)		$	5.94	$	583,645
Forfeited	44,250	(161,833)		$	7.01
Balance at December 31, 2020	1,576,722	8,520,610	5.57	$	6.17
Options vested and exercisable		5,497,662	4.02	$	5.70	$	9,735,923
Options vested and expected to vest		8,440,795	5.54	$	6.16	$	11,522,386

The weighted average fair value per underlying share of options granted during the three months ended December 31, 2020 and 2019 was $2.51 and $2.66, respectively, and $2.39 and $2.84 for the nine months ended December 31, 2020 and 2019, respectively.

Options outstanding by exercise price at December 31, 2020 were as follows:

				Number of	Options Outstanding			Options Exercisable
				Shares	Weighted		Weighted Average		Weighted
				Underlying	Average		Remaining	Number	Average
				Options	Exercise		Contractual	Vested and	Exercise
Exercise Price				Outstanding	Price		Life (Years)	Exercisable	Price
$	3.40	-	4.81	888,007	$	4.06	3.32	888,007	$	4.06
$	4.90	-	4.99	1,255,826	$	4.97	4.48	1,255,826	$	4.97
$	5.13	-	5.59	910,509	$	5.32	3.68	910,509	$	5.32
$	5.69	-	5.83	854,567	$	5.81	7.36	270,874	$	5.76
$	5.91	-	6.45	933,860	$	6.17	6.18	568,329	$	6.20
$	6.54	-	6.70	1,100,140	$	6.65	5.15	555,193	$	6.60
$	6.86	-	7.26	1,042,797	$	7.08	5.55	563,773	$	6.95
$	7.40	-	8.09	812,431	$	7.79	8.27	330,598	$	7.79
$	8.30			613,893	$	8.30	8.58	45,973	$	8.30
$	9.20			108,580	$	9.20	0.08	108,580	$	9.20
				8,520,610	$	6.17	5.57	5,497,662	$	5.70

The following table summarizes stock-based compensation expense by line item in the Condensed Consolidated Statements of Operations, all relating to employee stock plans:

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
				(In Thousands)
Cost of revenues	$	88	$	77	$	260	$	184
Research and development		343		347		1,109		1,143
Selling, general and administrative		262		205		732		595
Total	$	693	$	629	$	2,101	$	1,922

As stock-based compensation expense recognized in the Condensed Consolidated Statement of Operations is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures in accordance with authoritative guidance.  The Company estimates forfeitures at the time of grant and revises the original estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

No tax benefit related to stock-based compensation was recognized in the nine months ended December 31, 2020 due to a full valuation allowance. There were no windfall tax benefits realized from exercised stock options in either of these periods. Compensation cost capitalized within inventory at December 31, 2020 was immaterial. As of December 31, 2020, the Company’s total unrecognized compensation cost was $5.2 million, which will be recognized over a weighted average period of 2.09 years. The Company calculated the fair value of stock-based awards in the periods presented using the Black-Scholes option pricing model and the following weighted average assumptions:

	Three Months Ended December 31,						Nine Months Ended December 31,
	2020			2019					2020				2019
Stock Option Plans:
Risk-free interest rate		0.38	%		1.66	%	0.22	-	0.38	%	1.66	-	2.30	%
Expected life (in years)		5.00			5.00				5.00				5.00
Volatility		47.1	%		36.5	%	41.9	-	47.1	%	36.5	-	37.3	%
Dividend yield		—	%		—	%			—	%			—	%
Employee Stock Purchase Plan:
Risk-free interest rate		0.12	%		1.58	%	0.12	-	0.15	%	1.58	-	2.43	%
Expected life (in years)		0.50			0.50				0.50				0.50
Volatility		68.6	%		33.5	%	67.1	-	68.6	%	33.5	-	43.1	%
Dividend yield		—	%		—	%			—	%			—	%

XML

11. RELATED PARTY TRANSACTION

9 Months Ended

Dec. 31, 2020

RELATED PARTY TRANSACTION

NOTE 11 - RELATED PARTY TRANSACTION

NOTE 11—RELATED PARTY TRANSACTION

The Company incurred non-recurring engineering service expense of approximately $326,000 during the nine months ended December 31, 2020 from Wistron Neweb Corp (“WNC”) in connection with the manufacturing of  single-APU PCIe boards, to be used in the Company’s in-place associative computing product. Haydn Hsieh, a member of the Company’s board of directors, is the Chairman and Chief Strategy Officer of WNC. The amount owed to WNC, of $243,000 at December 31, 2020, is included in accounts payable in the Condensed Consolidated Balance Sheets.

XML

12. SEGMENT AND GEOGRAPHIC INFORMATION

9 Months Ended

Dec. 31, 2020

SEGMENT AND GEOGRAPHIC INFORMATION

NOTE 12 - SEGMENT AND GEOGRAPHIC INFORMATION

NOTE 12—SEGMENT AND GEOGRAPHIC INFORMATION

Based on its operating management and financial reporting structure, the Company has determined that it has one reportable business segment: the design, development and sale of integrated circuits.

The following is a summary of net revenues by geographic area based on the location to which product is shipped:

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands)
United States	$	3,550	$	4,408	$	9,363	$	12,794
China		760		1,221		1,762		4,590
Singapore		772		766		2,608		5,538
Netherlands		951		417		4,083		5,169
Germany		615		2,958		1,653		5,870
Rest of the world		115		279		574		847
	$	6,763	$	10,049	$	20,043	$	34,808

All sales are denominated in United States dollars.

XML

1. THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Dec. 31, 2020

The Company And Summary Of Significant Accounting Policies

Basis of presentation

Basis of presentation

The accompanying unaudited condensed consolidated financial statements of GSI Technology, Inc. and its subsidiaries (“GSI” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission.  Accordingly, the interim financial statements do not include all of the information and footnotes required by GAAP for annual financial statements.  These interim financial statements contain all adjustments (which consist of only normal, recurring adjustments) that are, in the opinion of management, necessary to state fairly the interim financial information included therein.  The Company believes that the disclosures are adequate to make the information not misleading.  However, these financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

The consolidated results of operations for the nine months ended December 31, 2020 are not necessarily indicative of the results to be expected for the entire fiscal year.

Significant accounting policies

Significant accounting policies

Except for the changes in disclosure requirements for recurring and nonrecurring fair value measurements and changes in goodwill impairment testing, which were updated as a result of adopting new accounting standards, there have been no material changes to our significant accounting policies that were disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

Risk and uncertainties

Risk and uncertainties

On March 11, 2020, the World Health Organization announced that COVID-19, a respiratory illness caused by a novel coronavirus, is a pandemic. COVID-19 has spread to many of the countries in which the Company, its customers, suppliers and other business partners conduct business. Governments in affected regions have implemented, and may continue to implement, safety precautions which include quarantines, travel restrictions, business closures, cancellations of public gatherings and other measures as they deem necessary. Many organizations and individuals, including the Company and its employees, are taking additional steps to avoid or reduce infection, including limiting travel and working from home. These measures are disrupting normal business operations both in and outside of affected areas and have had significant negative impacts on businesses and financial markets worldwide.

The Company continues to monitor its operations and government recommendations and has made modifications to its normal operations because of the COVID-19 global pandemic. The Company has instituted many preventative measures and is regularly evaluating those measures and others as it continues to better understand its current and future operating environment. Except for the Company’s employees located in Taiwan, the majority of its employees are working from home around the world. The Company has maintained a substantial portion of its manufacturing operational capacity at its primary manufacturing support facility located in Hsin Chu, Taiwan where the Company’s suppliers are located and where all of the Company’s products are manufactured. Since the outbreak of COVID-19, aside from the lengthening of lead times for wafers and assembly services, the Company has experienced minimal impact on its manufacturing operations in Taiwan. Final testing of the Company’s products is conducted in house. Shipping and receiving operations are being maintained by a skeleton crew with minimal impact. The Company’s revenues have been and are expected to continue to be impacted by changes in customer buying patterns and communication limitations related to shelter in place restrictions that require a significant number of its customer contacts to work from home. The Company’s results for the three month and nine month periods ended December 31, 2020 demonstrate the challenges that the Company is facing during the COVID-19 global pandemic, which has restricted the activities of the Company’s sales force and distributors, reduced customer demand and caused the postponement of investment in certain customer sectors. These challenges are also impacting the Company as it enters new markets and engages with target customers. Industry conferences and on-site training workshops, which are typically used for building a sales pipeline, are unavailable due to COVID-19 related restrictions. The Company has adapted its sales strategies for the COVID-19 environment, where it cannot do face-to-face meetings and conduct secure meetings with government and defense customers, but the Company is still not operating at an optimal level.

The disruption to the marketplace resulting from the COVID-19 global pandemic that the Company continues to experience is unlike anything the Company has ever had to deal with. While the Company continues to monitor the business metrics that it has historically used to predict its financial performance, the Company is uncertain as to whether these metrics will operate consistently with its historical experience.

The Company believes that during the next 12 months the COVID-19 pandemic could impact general economic activity and demand in its end markets. Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it is expected to have an adverse effect on the Company’s results of operations, financial position, and liquidity during fiscal year 2021 and into fiscal year 2022. This includes results from new information that may emerge concerning COVID-19 and any actions taken to contain or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. The Company has made estimates of the impact of COVID-19 within its financial statements and there may be changes to those estimates in future periods.

Accounting pronouncements recently adopted or not yet effective

Accounting pronouncements recently adopted

In August 2018, the Financial Accounting Standards Board (“FASB”)  issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement.” The standard amends the disclosure requirements for recurring and nonrecurring fair value measurements by removing, modifying, and adding certain disclosures. The Company adopted ASU No. 2018-13 in the quarter ended June 30, 2020.Implementation of this guidance did not have a material impact on the Company’s consolidated financial statements and related disclosures.

In January 2017, the FASB issued ASU No. 2017-04, "Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The standard eliminates the second step in the goodwill impairment test which requires an entity to determine the implied fair value of the reporting unit’s goodwill.  Instead, an entity should recognize an impairment loss if the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, with the impairment loss not to exceed the amount of goodwill allocated to the reporting unit. The Company adopted ASU No. 2017-04 in the quarter ended June 30, 2020.Implementation of this guidance did not have a material impact on the Company’s consolidated financial statements and related disclosures.

Accounting pronouncements not yet effective for fiscal 2021

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” as part of its initiative to reduce complexity in the accounting standards.The standard eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact that this guidance will have upon its financial position and results of operations, if any.

In June 2016, the FASB issued ASU No. 2016-13,  “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other receivables, loans, and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted beginning April 1, 2019. Application of the amendments is through a cumulative-effect adjustment to retained earnings as of the effective date. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

XML

2. REVENUE RECOGNITION (Tables)

9 Months Ended

Dec. 31, 2020

REVENUE RECOGNITION.

Summary of revenue disaggregated by customer type

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands)
Contract manufacturers	$	3,154	$	3,022	$	9,007	$	11,745
Distribution		3,586		6,603		10,692		21,346
OEMs		23		424		344		1,717
	$	6,763	$	10,049	$	20,043	$	34,808

XML

3. NET LOSS PER COMMON SHARE (Tables)

9 Months Ended

Dec. 31, 2020

NET LOSS PER COMMON SHARE

Basic and diluted net loss per share

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands, except per share amounts)
Net loss	$	(5,216)	$	(4,620)	$	(16,523)	$	(6,513)
Denominators:
Weighted average shares—Basic		23,716		23,096		23,592		22,894
Dilutive effect of employee stock options		—		—		—		—
Dilutive effect of employee stock purchase plan options		—		—		—		—
Weighted average shares—Dilutive		23,716		23,096		23,592		22,894
Net loss per common share—Basic	$	(0.22)	$	(0.20)	$	(0.70)	$	(0.28)
Net loss per common share—Diluted	$	(0.22)	$	(0.20)	$	(0.70)	$	(0.28)

Anti-dilutive shares

	Three Months Ended December 31,		Nine Months Ended December 31,
	2020	2019	2020	2019
	(In thousands)
Shares underlying options and ESPP shares	5,181	4,048	4,856	3,762

XML

4. BALANCE SHEET DETAIL (Tables)

9 Months Ended

Dec. 31, 2020

BALANCE SHEET DETAIL

Schedule of inventories

	December 31, 2020		March 31, 2020
	(In thousands)
Inventories:
Work-in-progress	$	1,924	$	1,650
Finished goods		2,572		2,612
Inventory at distributors		27		20
	$	4,523	$	4,282

Schedule of accounts receivable, net

	December 31, 2020		March 31, 2020
	(In thousands)
Accounts receivable, net:
Accounts receivable	$	4,072	$	6,415
Less: Allowances for doubtful accounts and other		(60)		(85)
	$	4,012	$	6,330

Schedule of prepaid expenses and other current assets

	December 31, 2020		March 31, 2020
	(In thousands)
Prepaid expenses and other current assets:
Prepaid tooling and masks	$	783	$	707
Prepaid income taxes		45		79
Other receivables		234		211
Other prepaid expenses and other current assets		917		937
	$	1,979	$	1,934

Schedule of property and equipment, net

	December 31, 2020		March 31, 2020
	(In thousands)
Property and equipment, net:
Computer and other equipment	$	18,289	$	18,191
Software		4,097		4,086
Land		3,900		3,900
Building and building improvements		3,735		3,735
Furniture and fixtures		102		102
Leasehold improvements		877		874
		31,000		30,888
Less: Accumulated depreciation		(23,556)		(22,769)
	$	7,444	$	8,119

Schedule of other assets

	December 31, 2020		March 31, 2020
	(In thousands)
Other assets:
Deposits	$	139	$	128
	$	139	$	128

Schedule of intangible assets

The following tables summarize the components of intangible assets and related accumulated amortization balances at December 31, 2020 and March 31, 2020 (in thousands):

	As of December 31, 2020
	Gross Carrying Amount		Accumulated amortization		Net Carrying Amount
Intangible assets:
Product designs	$	590	$	(590)	$	—
Patents		4,220		(1,906)		2,314
Software		80		(80)		—
Total	$	4,890	$	(2,576)	$	2,314

	As of March 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Intangible assets:
Product designs	$	590	$	(590)	$	—
Patents		4,220		(1,731)		2,489
Software		80		(80)		—
Total	$	4,890	$	(2,401)	$	2,489

Estimated future amortization expense of intangible assets

As of December 31, 2020, the estimated future amortization expense of intangible assets in the table above is as follows (in thousands):

Fiscal year ending March 31,
2021 (Remaining three months)	$	58
2022		233
2023		233
2024		233
2025		233
Thereafter		1,324
Total	$	2,314

Schedule of accrued expenses and other liabilities

	December 31, 2020		March 31, 2020
	(In thousands)
Accrued expenses and other liabilities:
Accrued compensation	$	3,959	$	3,673
Purchased intellectual property		—		1,621
Accrued commissions		223		270
Income taxes payable		211		143
Miscellaneous accrued expenses		1,132		871
	$	5,525	$	6,578

XML

7. FINANCIAL INSTRUMENTS (Tables)

9 Months Ended

Dec. 31, 2020

FINANCIAL INSTRUMENTS

Schedule of fair value of financial assets measured on a recurring basis

The fair value of financial assets measured on a recurring basis is as follows (in thousands):

			Fair Value Measurements at Reporting Date Using
			Quoted Prices
			in Active		Significant
			Markets for		Other		Significant
			Identical Assets		Observable		Unobservable
			and Liabilities		Inputs		Inputs
	December 31, 2020		(Level 1)		(Level 2)		(Level 3)
Assets:
Money market funds	$	23,160	$	23,160	$	—	$	—
Marketable securities		19,322		—		19,322		—
Total	$	42,482	$	23,160	$	19,322	$	—
Liabilities:
Contingent consideration	$	3,972	$	—	$	—	$	3,972

			Fair Value Measurements at Reporting Date Using
			Quoted Prices
			in Active		Significant
			Markets for		Other		Significant
			Identical Assets		Observable		Unobservable
			and Liabilities		Inputs		Inputs
	March 31, 2020		(Level 1)		(Level 2)		(Level 3)
Assets:
Money market funds	$	14,117	$	14,117	$	—	$	—
Marketable securities		19,178		—		19,178		—
Total	$	33,295	$	14,117	$	19,178	$	—
Liabilities:
Contingent consideration	$	3,898	$	—	$	—	$	3,898

Schedule of changes in fair value of contingent consideration

	Nine Months Ended December 31,
	2020		2019
	(In thousands)
Contingent consideration, beginning of period	$	3,898	$	4,206
Change due to accretion		74		87
Payment of contingent consideration		—		(500)
Contingent consideration, end of period	$	3,972	$	3,793

Schedule of available-for-sale investments

	December 31, 2020
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
	(In thousands)
Short-term investments:
Certificates of deposit	$	2,495	$	14	$	—	$	2,509
Supranational obligations		2,765		5		—		2,770
Agency bonds		3,918		—		(1)		3,917
Total short-term investments	$	9,178	$	19	$	(1)	$	9,196
Long-term investments:
Certificates of deposit	$	4,000	$	31	$	—	$	4,031
Supranational obligations		2,047		—		(1)		2,046
Agency bonds		4,018		31		—		4,049
Total long-term investments	$	10,065	$	62	$	(1)	$	10,126

	March 31, 2020
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
	(In thousands)
Short-term investments:
Certificates of deposit	$	12,000	$	52	$	(1)	$	12,051
Agency bonds		2,989		21		—		3,010
Total short-term investments	$	14,989	$	73	$	(1)	$	15,061
Long-term investments:
Certificates of deposit	$	745	$	18	$	—	$	763
Agency bonds		2,029		42		—		2,071
Supranational obligations		1,270		13		—		1,283
Total long-term investments	$	4,044	$	73	$	—	$	4,117

Schedule of unrealized losses and fair value of investments

	December 31, 2020
	Less Than 12 Months				12 Months or Greater				Total
		Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
		Value		Loss		Value		Loss		Value		Loss
	(In thousands)
Agency bonds	$	4,918	$	(1)	$	—	$	—	$	4,918	$	(1)
Certificates of deposit		250		(1)		—		—		250		(1)
Supranational obligations		2,523		(1)		—		—		2,523		(1)
	$	7,691	$	(3)	$	—	$	—	$	7,691	$	(3)

	March 31, 2020
	Less Than 12 Months				12 Months or Greater				Total
		Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
		Value		Loss		Value		Loss		Value		Loss
	(In thousands)
Certificates of deposit	$	2,498	$	(2)	$	-	$	-	$	2,498	$	(2)
	$	2,498	$	(2)	$	-	$	-	$	2,498	$	(2)

Schedule of contractual maturities of the available-for-sale investments

			Fair
	Cost		Value
	(In thousands)
Maturing within one year	$	9,178	$	9,196
Maturing in one to three years		10,065		10,126
	$	19,243	$	19,322

XML

8. LEASES (Tables)

9 Months Ended

Dec. 31, 2020

LEASES

Summary of balance sheet information related to leases

	As of		As of
	December 31, 2020		March 31, 2020
	(In thousands)
Operating Leases
Operating lease right-of-use assets	$	817	$	617
Lease liabilities-current	$	457	$	498
Lease liabilities-non-current		403		142
Total operating lease liabilities	$	860	$	640

Summary of components of lease costs

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands)				(In thousands)
Operating lease cost	$	172	$	164	$	504	$	483
Short-term lease cost		8		7		23		21
	$	180	$	171	$	527	$	504

Summary of other information related to leases

	Nine Months Ended December 31,
	2020		2019
	(In thousands)
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	175	$	488
Right-of-use assets obtained in exchange for lease obligations
Operating leases	$	658	$	1,228
Weighted-average remaining lease term (years):
Operating leases		2.2		1.5
Weighted-average discount rate:
Operating leases		4.86%		6.46%

Summary of maturities of the lease liabilities

	Operating Lease
	Liabilities
Fiscal Year	(In thousands)
2021 (Remaining three months)	$	154
2022		395
2023		251
2024		102
Total undiscounted future cash flows		902
Less: Imputed interest		(42)
Present value of undiscounted future cash flows	$	860
Presentation on statement of financial position
Current	$	457
Non-current	$	403

XML

10. STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Dec. 31, 2020

STOCK-BASED COMPENSATION

Summary of stock option activities

			Weighted
		Number of Shares	Average	Weighted
	Shares	Underlying	Remaining	Average
	Available for	Options	Contractual	Exercise		Intrinsic
	Grant	Outstanding	Life (Years)	Price		Value
Balance at March 31, 2020	2,522,314	8,135,791		$	6.17
Granted	(989,842)	989,842		$	6.14
Exercised	—	(443,190)		$	5.94	$	583,645
Forfeited	44,250	(161,833)		$	7.01
Balance at December 31, 2020	1,576,722	8,520,610	5.57	$	6.17
Options vested and exercisable		5,497,662	4.02	$	5.70	$	9,735,923
Options vested and expected to vest		8,440,795	5.54	$	6.16	$	11,522,386

Schedule of options outstanding by exercise price

				Number of	Options Outstanding			Options Exercisable
				Shares	Weighted		Weighted Average		Weighted
				Underlying	Average		Remaining	Number	Average
				Options	Exercise		Contractual	Vested and	Exercise
Exercise Price				Outstanding	Price		Life (Years)	Exercisable	Price
$	3.40	-	4.81	888,007	$	4.06	3.32	888,007	$	4.06
$	4.90	-	4.99	1,255,826	$	4.97	4.48	1,255,826	$	4.97
$	5.13	-	5.59	910,509	$	5.32	3.68	910,509	$	5.32
$	5.69	-	5.83	854,567	$	5.81	7.36	270,874	$	5.76
$	5.91	-	6.45	933,860	$	6.17	6.18	568,329	$	6.20
$	6.54	-	6.70	1,100,140	$	6.65	5.15	555,193	$	6.60
$	6.86	-	7.26	1,042,797	$	7.08	5.55	563,773	$	6.95
$	7.40	-	8.09	812,431	$	7.79	8.27	330,598	$	7.79
$	8.30			613,893	$	8.30	8.58	45,973	$	8.30
$	9.20			108,580	$	9.20	0.08	108,580	$	9.20
				8,520,610	$	6.17	5.57	5,497,662	$	5.70

Summary of stock-based compensation expense by line item

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
				(In Thousands)
Cost of revenues	$	88	$	77	$	260	$	184
Research and development		343		347		1,109		1,143
Selling, general and administrative		262		205		732		595
Total	$	693	$	629	$	2,101	$	1,922

Schedule of weighted average assumptions

	Three Months Ended December 31,						Nine Months Ended December 31,
	2020			2019					2020				2019
Stock Option Plans:
Risk-free interest rate		0.38	%		1.66	%	0.22	-	0.38	%	1.66	-	2.30	%
Expected life (in years)		5.00			5.00				5.00				5.00
Volatility		47.1	%		36.5	%	41.9	-	47.1	%	36.5	-	37.3	%
Dividend yield		—	%		—	%			—	%			—	%
Employee Stock Purchase Plan:
Risk-free interest rate		0.12	%		1.58	%	0.12	-	0.15	%	1.58	-	2.43	%
Expected life (in years)		0.50			0.50				0.50				0.50
Volatility		68.6	%		33.5	%	67.1	-	68.6	%	33.5	-	43.1	%
Dividend yield		—	%		—	%			—	%			—	%

XML

12. SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

9 Months Ended

Dec. 31, 2020

SEGMENT AND GEOGRAPHIC INFORMATION

Net revenues by geographic area

	Three Months Ended December 31,				Nine Months Ended December 31,
	2020		2019		2020		2019
	(In thousands)
United States	$	3,550	$	4,408	$	9,363	$	12,794
China		760		1,221		1,762		4,590
Singapore		772		766		2,608		5,538
Netherlands		951		417		4,083		5,169
Germany		615		2,958		1,653		5,870
Rest of the world		115		279		574		847
	$	6,763	$	10,049	$	20,043	$	34,808

XML

1. THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recent accounting pronouncements (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
The Company And Summary Of Significant Accounting Policies
Operating lease right-of-use assets	$ 817	$ 617
Lease liabilities, operating lease	$ 860	$ 640

XML

2. REVENUE RECOGNITION (Details)	9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Practical Expedient, Initial Application and Transition, Nondisclosure of Transaction Price Allocation to Remaining Performance Obligation [true false]	true
Revenue, Practical Expedient, Incremental Cost of Obtaining Contract [true/false]	true
Warranty period	3 years
SRAM products | Customer Concentration Risk
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Concentration risk percentage	98.00%
Sales revenue goods | Customer Concentration Risk
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Concentration risk percentage	40.00%	40.00%
Minimum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Payment terms	30 days
Maximum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Payment terms	60 days

XML

2. REVENUE RECOGNITION - Revenue disaggregated (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Net revenues	$ 6,763	$ 10,049	$ 20,043	$ 34,808
Contract Manufacturers
Disaggregation of Revenue [Line Items]
Net revenues	3,154	3,022	9,007	11,745
Distribution
Disaggregation of Revenue [Line Items]
Net revenues	3,586	6,603	10,692	21,346
OEMs
Disaggregation of Revenue [Line Items]
Net revenues	$ 23	$ 424	$ 344	$ 1,717

XML

3. NET LOSS PER COMMON SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
NET LOSS PER COMMON SHARE
Net loss	$ (5,216)	$ (4,620)	$ (16,523)	$ (6,513)
Weighted average shares - Basic	23,716	23,096	23,592	22,894
Weighted average shares - Dilutive	23,716	23,096	23,592	22,894
Net loss per common share - Basic	$ (0.22)	$ (0.20)	$ (0.70)	$ (0.28)
Net loss per common share - Diluted	$ (0.22)	$ (0.20)	$ (0.70)	$ (0.28)

XML

3. NET LOSS PER COMMON SHARE - Shares underlying options (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
NET LOSS PER COMMON SHARE
Shares underlying options and ESPP shares	5,181	4,048	4,856	3,762

XML

4. BALANCE SHEET DETAIL - Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
Inventories:
Work-in-progress	$ 1,924	$ 1,650
Finished goods	2,572	2,612
Inventory at distributors	27	20
Total inventory	$ 4,523	$ 4,282

XML

4. BALANCE SHEET DETAIL - Accounts receivable, net (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
Accounts receivable, net:
Accounts receivable	$ 4,072	$ 6,415
Less: Allowances for doubtful accounts and other	(60)	(85)
Total accounts receivable, net	$ 4,012	$ 6,330

XML

4. BALANCE SHEET DETAIL - Prepaid expenses and other current assets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
Prepaid expenses and other current assets:
Prepaid tooling and masks	$ 783	$ 707
Prepaid income taxes	45	79
Other receivables	234	211
Other prepaid expenses and other current assets	917	937
Total prepaid expenses and other current assets	$ 1,979	$ 1,934

XML

4. BALANCE SHEET DETAIL - Property and equipment, net (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Mar. 31, 2020
Property and equipment, net:
Property and equipment, gross	$ 31,000,000		$ 31,000,000		$ 30,888,000
Less: Accumulated depreciation	(23,556,000)		(23,556,000)		(22,769,000)
Total property and equipment, net	7,444,000		7,444,000		8,119,000
Depreciation	197,000	$ 293,000	787,000	$ 904,000
Computer and other equipment
Property and equipment, net:
Property and equipment, gross	18,289,000		18,289,000		18,191,000
Software
Property and equipment, net:
Property and equipment, gross	4,097,000		4,097,000		4,086,000
Land
Property and equipment, net:
Property and equipment, gross	3,900,000		3,900,000		3,900,000
Building and building improvements
Property and equipment, net:
Property and equipment, gross	3,735,000		3,735,000		3,735,000
Furniture and fixtures
Property and equipment, net:
Property and equipment, gross	102,000		102,000		102,000
Leasehold improvements
Property and equipment, net:
Property and equipment, gross	$ 877,000		$ 877,000		$ 874,000

XML

4. BALANCE SHEET DETAIL - Other assets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
Other assets:
Deposits	$ 139	$ 128
Total other assets	$ 139	$ 128

XML

4. BALANCE SHEET DETAIL - Intangible assets (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Mar. 31, 2020
Gross Carrying Amount	$ 4,890,000		$ 4,890,000		$ 4,890,000
Accumulated Amortization	(2,576,000)		(2,576,000)		(2,401,000)
Total	2,314,000		2,314,000		2,489,000
Amortization of intangible assets	58,000	$ 58,000	175,000	$ 175,000
Product designs
Gross Carrying Amount	590,000		590,000		590,000
Accumulated Amortization	(590,000)		(590,000)		(590,000)
Patents
Gross Carrying Amount	4,220,000		4,220,000		4,220,000
Accumulated Amortization	(1,906,000)		(1,906,000)		(1,731,000)
Total	2,314,000		2,314,000		2,489,000
Software.
Gross Carrying Amount	80,000		80,000		80,000
Accumulated Amortization	$ (80,000)		$ (80,000)		$ (80,000)

XML

4. BALANCE SHEET DETAIL - Future amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
Fiscal year ending March 31,
2021 (Remaining three months)	$ 58
2022	233
2023	233
2024	233
2025	233
Thereafter	1,324
Total	$ 2,314	$ 2,489

XML

4. BALANCE SHEET DETAIL - Accrued expenses and other liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
Accrued expenses and other liabilities:
Accrued compensation	$ 3,959	$ 3,673
Purchased intellectual property		1,621
Accrued commissions	223	270
Income taxes payable	211	143
Miscellaneous accrued expenses	1,132	871
Total accrued expenses and other liabilities	$ 5,525	$ 6,578

XML

5. GOODWILL (Details)	3 Months Ended	9 Months Ended
	Mar. 31, 2020 USD ($)	Dec. 31, 2020 USD ($) segment
GOODWILL
Number of reporting units | segment		1
Goodwill	$ 7,978,000	$ 7,978,000
Goodwill impairment	$ 0

XML

6. INCOME TAXES - Unrecognized tax benefits (Details) - USD ($)	3 Months Ended			9 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2020	Mar. 31, 2020
Unrecognized tax benefits, current	$ 0			$ 0			$ 0
Unrecognized tax benefits, noncurrent	326,000			326,000			613,000
Deferred tax assets unrecognized tax benefit	3,000,000			3,000,000
Valuation allowance	(12,400,000)			(12,400,000)			(9,400,000)
Net deferred tax asset	12,400,000			12,400,000			$ 9,400,000
Provision for income taxes	$ 90,000		$ 84,000	$ 639,000	$ 182,000
Effective annual income tax rate (as a percentage)				(3.40%)	(2.20%)
Israel Tax Authority [Member]
Provision for income taxes				$ 479,000
Income tax payment		$ 713,000
Israel Tax Authority [Member] | Accrued expenses and other liabilities
Income taxes, accrued						$ 713,000

XML

7. FINANCIAL INSTRUMENTS (Details) $ in Thousands	Dec. 31, 2020 USD ($)	Mar. 31, 2020 USD ($) item	Nov. 23, 2015 item
Fair value measurements
Short-term investments	$ 9,196	$ 15,061
Long-term investments	10,126	$ 4,117
Measurement input
Fair value measurements
Discount rate | item		0.145	0.148
Minimum
Fair value measurements
Probability rate		0.00
Maximum
Fair value measurements
Probability rate		0.10
Level 2 | Marketable securities
Fair value measurements
Short-term investments	9,200
Long-term investments	10,100
Other accrued expenses
Fair value measurements
Contingent consideration liability	4,000	$ 3,900
Recurring
Fair value measurements
Assets	42,482	33,295
Liabilities	3,972	3,898
Recurring | Money market funds
Fair value measurements
Money market funds	23,160	14,117
Recurring | Marketable securities
Fair value measurements
Marketable securities	19,322	19,178
Recurring | Level 1
Fair value measurements
Assets	23,160	14,117
Recurring | Level 1 | Money market funds
Fair value measurements
Money market funds	23,160	14,117
Recurring | Level 2
Fair value measurements
Assets	19,322	19,178
Recurring | Level 2 | Marketable securities
Fair value measurements
Marketable securities	19,322	19,178
Recurring | Level 3
Fair value measurements
Liabilities	$ 3,972	$ 3,898

XML

7. FINANCIAL INSTRUMENTS - Change in contingent consideration (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Changes in fair value of contingent consideration
Contingent consideration, beginning of period	$ 3,898	$ 4,206
Change due to accretion	74	87
Payment of contingent consideration		(500)
Contingent consideration, end of period	$ 3,972	$ 3,793

XML

7. FINANCIAL INSTRUMENTS - Available-for-sale investments (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
Available-for-sale investments
Cost	$ 19,243
Total	19,322
Short-term investments
Available-for-sale investments
Cost	9,178	$ 14,989
Gross Unrealized Gains	19	73
Gross Unrealized Losses	(1)	(1)
Total	9,196	15,061
Short-term investments | Certificates of deposit
Available-for-sale investments
Cost	2,495	12,000
Gross Unrealized Gains	14	52
Gross Unrealized Losses		(1)
Total	2,509	12,051
Short-term investments | Supranational obligations
Available-for-sale investments
Cost	2,765
Gross Unrealized Gains	5
Total	2,770
Short-term investments | Agency bonds
Available-for-sale investments
Cost	3,918	2,989
Gross Unrealized Gains		21
Gross Unrealized Losses	(1)
Total	3,917	3,010
Long-term investment
Available-for-sale investments
Cost	10,065	4,044
Gross Unrealized Gains	62	73
Gross Unrealized Losses	(1)
Total	10,126	4,117
Long-term investment | Certificates of deposit
Available-for-sale investments
Cost	4,000	745
Gross Unrealized Gains	31	18
Total	4,031	763
Long-term investment | Supranational obligations
Available-for-sale investments
Cost	2,047	1,270
Gross Unrealized Gains		13
Gross Unrealized Losses	(1)
Total	2,046	1,283
Long-term investment | Agency bonds
Available-for-sale investments
Cost	4,018	2,029
Gross Unrealized Gains	31	42
Total	$ 4,049	$ 2,071

XML

7. FINANCIAL INSTRUMENTS - Unrealized losses and fair value (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
Fair Value
Less Than 12 Months, Fair Value	$ 7,691	$ 2,498
Total, Fair Value	7,691	2,498
Unrealized Loss
Less Than 12 Months, Unrealized Loss	3	2
Total, Unrealized Loss	3	2
Certificates of deposit
Fair Value
Less Than 12 Months, Fair Value	250	2,498
Total, Fair Value	250	2,498
Unrealized Loss
Less Than 12 Months, Unrealized Loss	1	2
Total, Unrealized Loss	1	$ 2
Agency bonds
Fair Value
Less Than 12 Months, Fair Value	4,918
Total, Fair Value	4,918
Unrealized Loss
Less Than 12 Months, Unrealized Loss	1
Total, Unrealized Loss	1
Supranational obligations
Fair Value
Less Than 12 Months, Fair Value	2,523
Total, Fair Value	2,523
Unrealized Loss
Less Than 12 Months, Unrealized Loss	1
Total, Unrealized Loss	$ 1

XML

7. FINANCIAL INSTRUMENTS - Other information (Details) - USD ($)	9 Months Ended
	Dec. 31, 2020	Mar. 31, 2020
Other information
Maximum maturity period of investment portfolio	3 years
Deferred tax liability related to unrecognized gains and losses on short-term and long-term investments	$ 22,000	$ 30,000

XML

7. FINANCIAL INSTRUMENTS - Contractual maturities (Details) $ in Thousands	Dec. 31, 2020 USD ($)
FINANCIAL INSTRUMENTS
Maturing within one year, Cost	$ 9,178
Maturing in one to three years, Cost	10,065
Total	19,243
Maturing within one year, Fair Value	9,196
Maturing in one to three years, Fair Value	10,126
Total	$ 19,322

XML

8. LEASES - Operating leases (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2020	Mar. 31, 2020
Leases
Operating lease, option to extend	true
Operating lease, renewal term	5 years
Operating lease right-of-use assets	$ 817	$ 617
Lease liabilities, current	457	498
Lease liabilities, non-current	403	142
Total operating lease liabilities	$ 860	$ 640
Minimum
Leases
Operating lease, term of lease	2 months
Maximum
Leases
Operating lease, term of lease	32 months

XML

8. LEASES - Lease costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Components of lease costs
Operating lease cost	$ 172	$ 164	$ 504	$ 483
Short-term lease cost	8	7	23	21
Lease costs	$ 180	$ 171	$ 527	$ 504

XML

8. LEASES - Other information (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$ 175	$ 488
Right-of-use assets obtained in exchange for lease obligations - Operating leases	$ 658	$ 1,228
Weighted-average remaining lease term (years) - Operating leases	2 years 2 months 12 days	1 year 6 months
Weighted-average discount rate - Operating leases	4.86%	6.46%

XML

8. LEASES - Maturity of lease liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Mar. 31, 2020
Maturity of Lease Liabilities
2021 (Remaining three months)	$ 154
2022	395
2023	251
2024	102
Total	902
Less: Imputed interest	(42)
Total operating lease liabilities	860	$ 640
Current	457	498
Non-current	$ 403	$ 142

XML

9. COMMITMENTS AND CONTINGENCIES - Product warranties (Details)	9 Months Ended
	Dec. 31, 2020
Product warranties
Warranty period	3 years

XML

10. STOCK-BASED COMPENSATION - Stock option activities (Details)	9 Months Ended
	Dec. 31, 2020 USD ($) $ / shares shares
STOCK-BASED COMPENSATION
Shares available for grant, Beginning	2,522,314
Granted (in shares)	(989,842)
Forfeited (in shares)	44,250
Shares available for grant, Ending	1,576,722
Number of Shares Underlying Options Outstanding
Balance at the beginning of the period (in shares)	8,135,791
Granted (in shares)	989,842
Exercised (in shares)	(443,190)
Forfeited (in shares)	(161,833)
Balance at the end of the period (in shares)	8,520,610
Options vested and exercisable (in shares)	5,497,662
Options vested and expected to vest (in shares)	8,440,795
Weighted Average Remaining Contractual Life
Options weighted average remaining contractual life	5 years 6 months 26 days
Options vested and exercisable	4 years 7 days
Options vested and expected to vest	5 years 6 months 15 days
Weighted Average Exercise Price
Balance at the beginning of the period (in dollars per share) | $ / shares	$ 6.17
Granted (in dollars per share) | $ / shares	6.14
Exercised (in dollars per share) | $ / shares	5.94
Forfeited (in dollars per share) | $ / shares	7.01
Balance at the end of the period (in dollars per share) | $ / shares	6.17
Options vested and exercisable (in dollars per share) | $ / shares	5.70
Options vested and expected to vest (in dollars per share) | $ / shares	$ 6.16
Intrinsic Value
Exercised (in dollars) | $	$ 583,645
Options vested and exercisable (in dollars) | $	9,735,923
Options vested and expected to vest (in dollars) | $	$ 11,522,386

XML

10. STOCK-BASED COMPENSATION - Options outstanding by exercise price (Details) - $ / shares	9 Months Ended
	Dec. 31, 2020	Mar. 31, 2020
Options outstanding by exercise price
Exercise Price (in dollars per share)	$ 6.17	$ 6.17
Number of Shares Underlying Options Outstanding (in shares)	8,520,610
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 6.17
Options Outstanding, Weighted Average Remaining Contractual Life	5 years 6 months 26 days
Options Exercisable, Number Vested and Exercisable (in shares)	5,497,662
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 5.70
$3.40 - $4.81
Options outstanding by exercise price
Exercise Price, low end of range (in dollars per share)	3.40
Exercise Price, high end of range (in dollars per share)	$ 4.81
Number of Shares Underlying Options Outstanding (in shares)	888,007
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 4.06
Options Outstanding, Weighted Average Remaining Contractual Life	3 years 3 months 26 days
Options Exercisable, Number Vested and Exercisable (in shares)	888,007
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 4.06
$4.90 - $4.99
Options outstanding by exercise price
Exercise Price, low end of range (in dollars per share)	4.90
Exercise Price, high end of range (in dollars per share)	$ 4.99
Number of Shares Underlying Options Outstanding (in shares)	1,255,826
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 4.97
Options Outstanding, Weighted Average Remaining Contractual Life	4 years 5 months 23 days
Options Exercisable, Number Vested and Exercisable (in shares)	1,255,826
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 4.97
$5.13 - $5.59
Options outstanding by exercise price
Exercise Price, low end of range (in dollars per share)	5.13
Exercise Price, high end of range (in dollars per share)	$ 5.59
Number of Shares Underlying Options Outstanding (in shares)	910,509
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 5.32
Options Outstanding, Weighted Average Remaining Contractual Life	3 years 8 months 5 days
Options Exercisable, Number Vested and Exercisable (in shares)	910,509
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 5.32
$5.69 - $5.83
Options outstanding by exercise price
Exercise Price, low end of range (in dollars per share)	5.69
Exercise Price, high end of range (in dollars per share)	$ 5.83
Number of Shares Underlying Options Outstanding (in shares)	854,567
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 5.81
Options Outstanding, Weighted Average Remaining Contractual Life	7 years 4 months 10 days
Options Exercisable, Number Vested and Exercisable (in shares)	270,874
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 5.76
$5.91 - $6.45
Options outstanding by exercise price
Exercise Price, low end of range (in dollars per share)	5.91
Exercise Price, high end of range (in dollars per share)	$ 6.45
Number of Shares Underlying Options Outstanding (in shares)	933,860
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 6.17
Options Outstanding, Weighted Average Remaining Contractual Life	6 years 2 months 5 days
Options Exercisable, Number Vested and Exercisable (in shares)	568,329
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 6.20
$6.54 - $6.70
Options outstanding by exercise price
Exercise Price, low end of range (in dollars per share)	6.54
Exercise Price, high end of range (in dollars per share)	$ 6.70
Number of Shares Underlying Options Outstanding (in shares)	1,100,140
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 6.65
Options Outstanding, Weighted Average Remaining Contractual Life	5 years 1 month 24 days
Options Exercisable, Number Vested and Exercisable (in shares)	555,193
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 6.60
$6.86 - $7.26
Options outstanding by exercise price
Exercise Price, low end of range (in dollars per share)	6.86
Exercise Price, high end of range (in dollars per share)	$ 7.26
Number of Shares Underlying Options Outstanding (in shares)	1,042,797
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 7.08
Options Outstanding, Weighted Average Remaining Contractual Life	5 years 6 months 18 days
Options Exercisable, Number Vested and Exercisable (in shares)	563,773
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 6.95
$7.40 - $8.09
Options outstanding by exercise price
Exercise Price, low end of range (in dollars per share)	7.40
Exercise Price, high end of range (in dollars per share)	$ 8.09
Number of Shares Underlying Options Outstanding (in shares)	812,431
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 7.79
Options Outstanding, Weighted Average Remaining Contractual Life	8 years 3 months 7 days
Options Exercisable, Number Vested and Exercisable (in shares)	330,598
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 7.79
$8.30
Options outstanding by exercise price
Exercise Price (in dollars per share)	$ 8.30
Number of Shares Underlying Options Outstanding (in shares)	613,893
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 8.30
Options Outstanding, Weighted Average Remaining Contractual Life	8 years 6 months 29 days
Options Exercisable, Number Vested and Exercisable (in shares)	45,973
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 8.30
$9.20
Options outstanding by exercise price
Exercise Price (in dollars per share)	$ 9.20
Number of Shares Underlying Options Outstanding (in shares)	108,580
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 9.20
Options Outstanding, Weighted Average Remaining Contractual Life	29 days
Options Exercisable, Number Vested and Exercisable (in shares)	108,580
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 9.20

XML

10. STOCK-BASED COMPENSATION - Stock-based compensation expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Stock-based compensation expense by line item
Stock-based compensation expense	$ 693	$ 629	$ 2,101	$ 1,922
Cost of revenues
Stock-based compensation expense by line item
Stock-based compensation expense	88	77	260	184
Research and development
Stock-based compensation expense by line item
Stock-based compensation expense	343	347	1,109	1,143
Selling, general and administrative
Stock-based compensation expense by line item
Stock-based compensation expense	$ 262	$ 205	$ 732	$ 595

XML

10. STOCK-BASED COMPENSATION - Weighted average assumptions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Other information
Income tax benefit recognized from allocation of share-based compensation expense			$ 0
Windfall tax benefits realized			0
Unrecognized compensation costs	$ 5,200,000		$ 5,200,000
Weighted average period of recognition of unrecognized compensation costs			2 years 1 month 2 days
Weighted average fair value per underlying share of options granted (in dollars per share)	$ 2.51	$ 2.66	$ 2.39	$ 2.84
Employee stock options
Stock-based compensation
Risk-free interest rate (as a percent)	0.38%	1.66%
Risk-free interest rate, low end of range (as a percent)			0.22%	1.66%
Risk-free interest rate, high end of range (as a percent)			0.38%	2.30%
Expected life	5 years	5 years	5 years	5 years
Volatility (as a percent)	47.10%	36.50%
Volatility, low end of range (as a percent)			41.90%	36.50%
Volatility, high end of range (as a percent)			47.10%	37.30%
Employee stock purchase plan options
Stock-based compensation
Risk-free interest rate (as a percent)	0.12%	1.58%
Risk-free interest rate, low end of range (as a percent)			0.12%	1.58%
Risk-free interest rate, high end of range (as a percent)			0.15%	2.43%
Expected life	6 months	6 months	6 months	6 months
Volatility (as a percent)	68.60%	33.50%
Volatility, low end of range (as a percent)			67.10%	33.50%
Volatility, high end of range (as a percent)			68.60%	43.10%

XML

11. RELATED PARTY TRANSACTION (Details)	9 Months Ended
	Dec. 31, 2020 USD ($)
Related Party Transaction [Line Items]
Amount owed to WNC	$ 243,000
Non-Recurring Engineering Services | Wistron Neweb Corp
Related Party Transaction [Line Items]
Non-recurring engineering service expense	$ 326,000

XML

12. SEGMENT AND GEOGRAPHIC INFORMATION - Revenue (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2020 USD ($) segment	Dec. 31, 2019 USD ($)
Net revenues by geographic area
Net revenues	$ 6,763	$ 10,049	$ 20,043	$ 34,808
Number of reporting units | segment			1
United States
Net revenues by geographic area
Net revenues	3,550	4,408	$ 9,363	12,794
China
Net revenues by geographic area
Net revenues	760	1,221	1,762	4,590
Singapore
Net revenues by geographic area
Net revenues	772	766	2,608	5,538
Netherlands
Net revenues by geographic area
Net revenues	951	417	4,083	5,169
Germany
Net revenues by geographic area
Net revenues	615	2,958	1,653	5,870
Rest of the world
Net revenues by geographic area
Net revenues	$ 115	$ 279	$ 574	$ 847